Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(1420).(05).Orthopedics Department Case No (185):-Low Back Pain (LBP), Suspected Nonspecific Mechanical Low Back Pain with Possible Lumbar Muscle Spasm (1Prescription+0Report+0Image)0987

Prescription attached:-

đŸŠē LIPU MED — COMPLETE CLINICAL CASE REVIEW

Prescription Analysis | Clinical Working Diagnosis | MedEx Bangladesh Drug Review | Evidence-Based Management | Doctor’s Dx vs My Dx Comparison

āĻŦāĻžāĻ‚āϞāĻž āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ: āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻž (Low Back Pain)āĨ¤ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖ āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄ āĻ“ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āϏāĻŽāĻ¸ā§āϝāĻž (Mechanical Low Back Pain), āϝāĻžāϰ āϏāĻ™ā§āϗ⧇ āϕ⧋āĻŽāϰ⧇āϰ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϤ⧇ āϟāĻžāύ āĻŦāĻž āĻ–āĻŋāρāϚ⧁āύāĻŋ (Lumbar Muscle Spasm) āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϰ⧋āĻ— āĻŦāĻž āĻ•āĻžāϰāĻŖ āĻāĻ–āύ⧋ āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧāĨ¤

Clinical Status: Provisional Working Diagnosis — āĻĒā§āϰāĻžāĻĨāĻŽāĻŋāĻ• āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧāĨ¤

Overall Diagnostic Confidence: 0.78/1.00

Prescription: 1

Investigation Report: 0

Additional Clinical Image: 0

Publication Date: Wednesday, 21 October 2026

✅ Corrected Medicine Identification

āφāĻĒāύāĻžāϰ āϏāĻ‚āĻļā§‹āϧāύ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ ā§Ē āύāĻŽā§āĻŦāϰ āĻ“āώ⧁āϧāϟāĻŋ Sante āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ…āĻ¨ā§āϤāĻ°ā§āϭ⧁āĻ•ā§āϤ āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

MedEx āϝāĻžāϚāĻžāχ āĻ•āϰ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āϏāĻ āĻŋāĻ• āϤāĻĨā§āϝ:

Brand: Sante

Generic: Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C

Form: Effervescent Tablet

Manufacturer: Healthcare Pharmaceuticals Ltd.

Important: Sante-āĻāϰ āĻāχ formulation-āĻ Vitamin D3 āύ⧇āχāĨ¤ āĻāϟāĻŋ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻ“ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ C-āĻāϰ combinationāĨ¤


đŸŸĸ SECTION 01 | Website-Verified Case Identification / āĻ“āϝāĻŧ⧇āĻŦāϏāĻžāχāϟ āϝāĻžāϚāĻžāχāĻ•ā§ƒāϤ āϕ⧇āϏ āĻĒāϰāĻŋāϚāĻŋāϤāĻŋ

Website: raiyyantahsan.com

āĻ“āϝāĻŧ⧇āĻŦāϏāĻžāχāĻŸā§‡āϰ Medical Blog āĻ“ Orthopedics āĻŦāĻŋāĻ­āĻžāĻ— āϝāĻžāϚāĻžāχ āĻ•āϰ⧇ āύāĻŋāĻšā§‡āϰ āϤāĻĨā§āϝ āĻĒāĻžāĻ“āϝāĻŧāĻž āϗ⧇āϛ⧇āĨ¤

Parameter / āĻŦāĻŋāώāϝāĻŧVerified Information / āϝāĻžāϚāĻžāχāĻ•ā§ƒāϤ āϤāĻĨā§āϝ
Latest Published Global TCTC (1418)
Latest Orthopedics CaseCase No (184)
Department Code05
Proposed New Global TCTC (1419)
Proposed Orthopedics Case185
DepartmentOrthopedics / āĻ…āĻ°ā§āĻĨā§‹āĻĒ⧇āĻĄāĻŋāĻ•ā§āϏ
Current CaseLow Back Pain
Case StatusNew proposed publication number

āϏāĻ°ā§āĻŦāĻļ⧇āώ āĻĒā§āϰāĻ•āĻžāĻļāĻŋāϤ Orthopedics Case No (184)-āĻāϰ āĻŦāĻŋāώāϝāĻŧ āĻ›āĻŋāϞ Suspected Musculoskeletal Chest Wall PaināĨ¤ āύāϤ⧁āύ āύāĻŋāĻŦāĻ¨ā§āϧ⧇āϰ āϜāĻ¨ā§āϝ āϤāĻžāχ TC (1419) āĻāĻŦāĻ‚ Orthopedics Case No (185) āĻĒā§āϰāĻ¸ā§āϤāĻžāĻŦ āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

Website Verification Confidence: 0.99

Limitation: āύāĻŽā§āĻŦāϰ āĻĻ⧁āϟāĻŋ āĻāĻ–āύ⧋ āĻĒā§āϰāĻ•āĻžāĻļ āĻŦāĻž reserve āĻ•āϰāĻž āĻšāϝāĻŧāύāĻŋāĨ¤ āĻĒāϰāĻŦāĻ°ā§āϤ⧀āϤ⧇ āύāϤ⧁āύ āĻĒā§‹āĻ¸ā§āϟ āĻĒā§āϰāĻ•āĻžāĻļāĻŋāϤ āĻšāϞ⧇ numbering āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤


đŸŸĸ SECTION 02 | Original Prescription Review / āĻŽā§‚āϞ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ

A. Patient Identification / āϰ⧋āĻ—ā§€āϰ āĻĒāϰāĻŋāϚāϝāĻŧ

Clinical ParameterPrescription Finding
Patient Name / āϰ⧋āĻ—ā§€āϰ āύāĻžāĻŽāĻšāĻžāϤ⧇āϰ āϞ⧇āĻ–āĻž āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ
Age / āĻŦāϝāĻŧāϏāύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻž
Sex / āϞāĻŋāĻ™ā§āĻ—āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧ
Registration NumberāĻ¸ā§āĻĒāĻˇā§āϟ āύāϝāĻŧ
Prescription DateāύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻž
Doctor’s SpecialtyOrthopedics — āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ
C/C — Chief ComplaintProbable LBP
O/E — On ExaminationāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
I/H — Illness HistoryāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
O/H — Obstetric HistoryāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
D/H — Drug HistoryāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
M/H — Medical HistoryāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
O/S/E — Systemic ExaminationāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
O/G/E — Obstetric/Gynecological ExaminationāωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
Dx — DiagnosisProbable LBP
Ix — InvestigationsāĻ¸ā§āĻĒāĻˇā§āϟ āϕ⧋āύ⧋ āĻĒāϰ⧀āĻ•ā§āώāĻž āύ⧇āχ
Plan — Treatment PlanāĻĒā§āϰāϧāĻžāύāϤ medication-based treatment
Advice — āĻĒāϰāĻžāĻŽāĻ°ā§āĻļāĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āĻĒāĻĄāĻŧāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻž

Prescription Reading Confidence: 0.76

B. Doctor’s Prescribed Medicines / āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϞāĻŋāĻ–āĻŋāϤ āĻ“āώ⧁āϧ

No.BrandGenericPrescription Confidence
1Flexi 100 mgAceclofenac0.92
2Seclo 20 mgOmeprazole0.91
3RelentusTizanidine Hydrochloride0.83
4Sante ✅Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C1.00 — user-confirmed brand

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻāϕ⧇āĻŦāĻžāϰ⧇ āύāĻŋāĻšā§‡āϰ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āϞ⧇āĻ–āĻžāϟāĻŋ āĻ“āώ⧁āϧ, follow-up instruction āύāĻžāĻ•āĻŋ āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āύ⧋āĻŸâ€”āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤ āϤāĻžāχ āϏ⧇āϟāĻŋāϕ⧇ āĻĒāĻžā§āϚāĻŽ āĻ“āώ⧁āϧ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ—āĻŖāύāĻž āĻ•āϰāĻž āĻšāĻšā§āϛ⧇ āύāĻžāĨ¤

āϚāĻžāϰāϟāĻŋ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄā§‡āϰ MedEx generic āĻ“ therapeutic classification āϝāĻžāϚāĻžāχāĻ•ā§ƒāϤāĨ¤


đŸŸĸ SECTION 03 | Chief Complaint (C/C) / āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāϧāĻžāύ āĻ…āĻ­āĻŋāϝ⧋āĻ—

3.1 Doctor’s Documented Complaint

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļ⧇ āϏāĻŽā§āĻ­āĻŦāϤ LBP āϞ⧇āĻ–āĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

LBP = Low Back Pain — āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻžāĨ¤

Definition / āϏāĻ‚āĻœā§āĻžāĻž

Low Back Pain āĻŦāϞāϤ⧇ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĒāĻŋāϠ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇, āύāĻŋāĻŽā§āύāϤāĻŽ āĻĒāĻžāρāϜāϰ āĻāĻŦāĻ‚ āύāĻŋāϤāĻŽā§āĻŦ⧇āϰ āĻ“āĻĒāϰ⧇āϰ āĻ­āĻžāρāĻœā§‡āϰ āĻŽāĻ§ā§āϝāĻŦāĻ°ā§āϤ⧀ āĻ…āĻžā§āϚāϞ⧇ āĻŦā§āϝāĻĨāĻž āĻŦāĻž āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋāϕ⧇ āĻŦā§‹āĻāĻžāϝāĻŧāĨ¤

Possible Symptoms / āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϞāĻ•ā§āώāĻŖ

1. Lumbar Pain — āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻž: āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻžāĨ¤

2. Muscle Stiffness — āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋ āĻļāĻ•ā§āϤ āĻšāϝāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻž: āϕ⧋āĻŽāϰ āύāĻĄāĻŧāĻžāϚāĻĄāĻŧāĻžāϝāĻŧ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋāĨ¤

3. Muscle Spasm — āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϤ⧇ āĻ–āĻŋāρāϚ⧁āύāĻŋ: āϕ⧋āĻŽāϰ⧇āϰ āĻĒ⧇āĻļāĻŋ āĻ…āύāĻŋāĻšā§āĻ›āĻžāĻ•ā§ƒāϤāĻ­āĻžāĻŦ⧇ āϏāĻ‚āϕ⧁āϚāĻŋāϤ āĻšāĻ“āϝāĻŧāĻžāĨ¤

4. Restricted Movement — āύāĻĄāĻŧāĻžāϚāĻĄāĻŧāĻž āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻž: āϏāĻžāĻŽāύ⧇ āĻā§āρāĻ•āϤ⧇ āĻŦāĻž āϏ⧋āϜāĻž āĻšāϤ⧇ āĻ…āϏ⧁āĻŦāĻŋāϧāĻžāĨ¤

5. Radiating Pain — āĻ›āĻĄāĻŧāĻŋāϝāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻž āĻŦā§āϝāĻĨāĻž: āϕ⧋āύ⧋ āϕ⧋āύ⧋ āϰ⧋āĻ—ā§€āϰ āϕ⧋āĻŽāϰ āĻĨ⧇āϕ⧇ āύāĻŋāϤāĻŽā§āĻŦ āĻŦāĻž āĻĒāĻžāϝāĻŧ⧇āϰ āĻĻāĻŋāϕ⧇ āĻŦā§āϝāĻĨāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Clinical Interpretation: āĻĒā§āϰāĻĨāĻŽ āωāĻĒāϏāĻ°ā§āĻ—āϟāĻŋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ LBP notation-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤ āĻŦāĻžāĻ•āĻŋ āωāĻĒāϏāĻ°ā§āĻ—āϗ⧁āϞ⧋ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āύāĻĨāĻŋāϭ⧁āĻ•ā§āϤ āύāϝāĻŧāĨ¤

Clinical Confidence: 0.82


đŸŸĸ SECTION 04 | Patient History Assessment / āϰ⧋āĻ—ā§€āϰ āχāϤāĻŋāĻšāĻžāϏ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ

4.1 I/H — Illness History / āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ…āϏ⧁āĻ¸ā§āĻĨāϤāĻžāϰ āχāϤāĻŋāĻšāĻžāϏ

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻŦā§āϝāĻĨāĻžāϰ āĻ¸ā§āĻĨāĻžāϝāĻŧāĻŋāĻ¤ā§āĻŦ āĻŦāĻž onset āĻ¸ā§āĻĒāĻˇā§āϟ āύāϝāĻŧāĨ¤

āύāĻŋāĻšā§‡āϰ āĻŦāĻŋāώāϝāĻŧāϗ⧁āϞ⧋ āϜāĻŋāĻœā§āĻžā§‡āϏ āĻ•āϰāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Clinical QuestionāĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨDocumentation
OnsetāĻŦā§āϝāĻĨāĻž āĻ•āĻŦ⧇ āĻļ⧁āϰ⧁ āĻšāϝāĻŧ⧇āϛ⧇?Unknown
DurationāĻ•āϤ āĻĻāĻŋāύ āϧāϰ⧇ āĻŦā§āϝāĻĨāĻž?Unknown
Locationāϕ⧋āĻŽāϰ⧇āϰ āĻ āĻŋāĻ• āϕ⧋āĻĨāĻžāϝāĻŧ āĻŦā§āϝāĻĨāĻž?Probable lumbar region
RadiationāĻŦā§āϝāĻĨāĻž āĻ•āĻŋ āĻĒāĻžāϝāĻŧ⧇ āĻ›āĻĄāĻŧāĻžāϝāĻŧ?Unknown
Pain SeverityāĻŦā§āϝāĻĨāĻžāϰ āϤ⧀āĻŦā§āϰāϤāĻž āĻ•āϤ?Unknown
Morning StiffnessāϏāĻ•āĻžāϞ⧇ āϕ⧋āĻŽāϰ āĻļāĻ•ā§āϤ āĻšāϝāĻŧ⧇ āĻĨāĻžāϕ⧇?Unknown
Traumaāϕ⧋āύ⧋ āφāϘāĻžāϤ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āφāϛ⧇?Unknown
Neurological SymptomsāĻĒāĻžāϝāĻŧ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻŦāĻž āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž āφāϛ⧇?Unknown

4.2 O/H — Obstetric History / āĻĒā§āϰāϏ⧂āϤāĻŋāϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āχāϤāĻŋāĻšāĻžāϏ

Doctor’s Documentation: Not mentioned — āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

āϰ⧋āĻ—ā§€ āĻĒā§āϰāϜāύāύāĻ•ā§āώāĻŽ āύāĻžāϰ⧀ āĻšāϞ⧇ Pregnancy Status — āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻž āφāϛ⧇ āĻ•āĻŋ āύāĻž — āϜāĻžāύāĻž āϜāϰ⧁āϰāĻŋāĨ¤ āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ NSAID āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āφāϗ⧇āĨ¤

4.3 D/H — Drug History / āĻ“āώ⧁āϧ āĻ—ā§āϰāĻšāϪ⧇āϰ āĻĒā§‚āĻ°ā§āĻŦ āχāϤāĻŋāĻšāĻžāϏ

Doctor’s Documentation: Not mentioned.

āϜāĻžāύāϤ⧇ āĻšāĻŦ⧇ āĻĒā§‚āĻ°ā§āĻŦ⧇ NSAID, corticosteroid, anticoagulant, antihypertensive āĻ•āĻŋāĻ‚āĻŦāĻž āĻ…āĻ¨ā§āϝ muscle relaxant āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšāϝāĻŧ⧇āϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤

4.4 M/H — Medical History / āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ āϰ⧋āϗ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ

āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϰ⧋āϗ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ:

  • Peptic Ulcer Disease — āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀ āĻŦāĻž āĻĄā§āĻ“āĻĄā§‡āύāĻžāĻŽā§‡āϰ āφāϞāϏāĻžāϰāĨ¤
  • Chronic Kidney Disease — āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āĻ•āĻŋāĻĄāύāĻŋ āϰ⧋āĻ—āĨ¤
  • Hypertension — āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒāĨ¤
  • Diabetes Mellitus — āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏāĨ¤
  • Osteoporosis — āĻšāĻžāĻĄāĻŧ⧇āϰ āϘāύāĻ¤ā§āĻŦ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻžāϰ āϰ⧋āĻ—āĨ¤
  • Previous Spinal Disease — āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āϰ⧋āĻ—āĨ¤

āĻāϏāĻŦ āϰ⧋āϗ⧇āϰ āϕ⧋āύ⧋āϟāĻŋāχ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

4.5 Other Relevant History / āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āχāϤāĻŋāĻšāĻžāϏ

Surgical History: āĻĒā§‚āĻ°ā§āĻŦ⧇ āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āĻ…āĻĒāĻžāϰ⧇āĻļāύ āĻšāϝāĻŧ⧇āϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤

Allergy History: āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ NSAID allergy āφāϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤

Occupational History: āĻĻā§€āĻ°ā§āϘāĻ•ā§āώāĻŖ āĻŦāϏ⧇ āĻ•āĻžāϜ āĻ•āϰāĻž, āĻ­āĻžāϰ⧀ āϜāĻŋāύāĻŋāϏ āϤ⧋āϞāĻž āĻŦāĻž repetitive bending-āĻāϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤

Family History: āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• rheumatological disease-āĻāϰ āĻĒāĻžāϰāĻŋāĻŦāĻžāϰāĻŋāĻ• āχāϤāĻŋāĻšāĻžāϏāĨ¤

History Assessment Confidence: 0.99 — āĻāϗ⧁āϞ⧋ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ history items; āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāĻ•ā§ƒāϤ history āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤


đŸŸĸ SECTION 05 | O/E, O/S/E & O/G/E — Clinical Examination / āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž

5.1 O/E — On Examination

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝ examination findings āύ⧇āχāĨ¤

Low Back Pain āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ⧇ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āĻĒāϰ⧀āĻ•ā§āώāĻžāϗ⧁āϞ⧋:

ExaminationEnglish Finding to AssessāĻŦāĻžāĻ‚āϞāĻž āωāĻĻā§āĻĻ⧇āĻļā§āϝ
General ExaminationVital signs, fever, general conditionāϏāĻžāϧāĻžāϰāĻŖ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻ…āĻŦāĻ¸ā§āĻĨāĻž
Spine InspectionPosture, deformity, spinal alignmentāĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āĻ—āĻ āύ
Lumbar PalpationTenderness, paraspinal spasmāϚāĻžāĻĒ āĻĻāĻŋāϞ⧇ āĻŦā§āϝāĻĨāĻž āĻŦāĻž āĻĒ⧇āĻļāĻŋāϤ⧇ āϟāĻžāύ
Range of MotionFlexion, extension, lateral movementāϕ⧋āĻŽāϰ⧇āϰ āύāĻĄāĻŧāĻžāϚāĻĄāĻŧāĻž
SLR TestStraight Leg RaisingāĻ¸ā§āύāĻžāϝāĻŧ⧁āĻŽā§‚āϞ⧇āϰ irritation-āĻāϰ āϞāĻ•ā§āώāĻŖ
Motor ExaminationLower-limb muscle powerāĻĒāĻžāϝāĻŧ⧇āϰ āĻļāĻ•ā§āϤāĻŋ
Sensory ExaminationDermatomal sensationāĻĒāĻžāϝāĻŧ⧇āϰ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ
Reflex ExaminationKnee and ankle reflexesāĻ¸ā§āύāĻžāϝāĻŧ⧁āϰ reflex
Gait ExaminationWalking patternāĻšāĻžāρāϟāĻžāϰ āϧāϰāύ

SLR Positive āĻĨāĻžāĻ•āϞ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ clinical context-āĻ lumbosacral nerve-root irritation-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āĻŦāĻžāĻĄāĻŧāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ SLR āĻāĻ•āĻž disc herniation āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰ⧇ āύāĻžāĨ¤

5.2 O/S/E — Other/Systemic Examination

āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧇ abdominal, vascular āĻ“ neurological examination āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāϰ āĻ•āĻžāϰāĻŖ āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āĻ…āĻ™ā§āĻ— āĻĨ⧇āϕ⧇ āφāϏāϛ⧇ āĻ•āĻŋ āύāĻž āĻāĻŦāĻ‚ āĻ¸ā§āύāĻžāϝāĻŧ⧁āϰ āϏāĻŽāĻ¸ā§āϝāĻž āφāϛ⧇ āĻ•āĻŋ āύāĻž āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύāĨ¤

5.3 O/G/E — Obstetric/Gynecological Examination

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• reproductive āĻŦāĻž pelvic symptoms āĻĨāĻžāĻ•āϞ⧇ āφāϞāĻžāĻĻāĻž gynecological assessment āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Examination Recommendation Confidence: 0.98


đŸŸĸ SECTION 06 | Investigations & Diagnostic Reports / āĻĒāϰ⧀āĻ•ā§āώāĻž-āύāĻŋāϰ⧀āĻ•ā§āώāĻž āĻ“ āϰāĻŋāĻĒā§‹āĻ°ā§āϟ

6.1 Doctor’s Prescribed Investigation

No clearly documented investigation.

āĻ›āĻŦāĻŋāϤ⧇ X-ray, MRI āĻŦāĻž Laboratory Investigation āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

6.2 Guideline-Based Recommended Investigations

InvestigationWhen AppropriateāĻŦāĻžāĻ‚āϞāĻž āĻŦā§āϝāĻžāĻ–ā§āϝāĻž
X-ray Lumbosacral SpineSuspected fracture or selected bony pathologyāĻšāĻžāĻĄāĻŧ āĻ­āĻžāĻ™āĻž āĻŦāĻž āĻ—āĻ āύāĻ—āϤ āϏāĻŽāĻ¸ā§āϝāĻž āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇
MRI Lumbosacral SpineSerious neurological compression, cauda equina, infection, malignancy or specialist-directed assessmentāϗ⧁āϰ⧁āϤāϰ āĻ¸ā§āύāĻžāϝāĻŧ⧁ āĻŦāĻž āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āϰ⧋āĻ— āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇
CBCSuspected infection or systemic diseaseāϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŦāĻž āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽāĻŋāĻ• āϰ⧋āϗ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž
ESR/CRPSelected inflammatory or infectious conditionsāĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ
Serum Creatinine/eGFRRenal-risk assessment before or during NSAID therapy when indicatedāĻ•āĻŋāĻĄāύāĻŋāϰ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āώāĻŽāϤāĻž
Serum CalciumSuspected calcium disorderāϰāĻ•ā§āϤ⧇āϰ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ
25-OH Vitamin DSelected patients with suspected deficiency or metabolic bone diseaseāĻ­āĻŋāϟāĻžāĻŽāĻŋāύ D-āĻāϰ āϘāĻžāϟāϤāĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ
DXA ScanWhen osteoporosis risk assessment indicates bone-density testingāĻšāĻžāĻĄāĻŧ⧇āϰ āϘāύāĻ¤ā§āĻŦ āĻĒāϰ⧀āĻ•ā§āώāĻž

Important Clinical Point

Sante prescribed ≠ Confirmed Calcium Deficiency.

Sante āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇āϛ⧇ āĻŦāϞ⧇ āϰ⧋āĻ—ā§€āϰ calcium deficiency āĻŦāĻž osteoporosis āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧāĨ¤

NICE Recommendation

Red flag āĻ›āĻžāĻĄāĻŧāĻž āϏāĻžāϧāĻžāϰāĻŖ Low Back Pain-āĻ routine imaging āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻšāϝāĻŧ āύāĻžāĨ¤ Specialist setting-āĻ imaging āĻĢāϞāĻžāĻĢāϞ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻ•āϰāĻŦ⧇ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāϞ⧇ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

Investigation Assessment Confidence: 0.98


🟩 SECTION 07 | PRESCRIBED DRUG ANALYSIS — MEDEX āĻ…āύ⧁āϝāĻžāϝāĻŧā§€

💊 DRUG 01 — FLEXI 100 mg

Brand Identification Confidence: 0.92

MedEx Pharmacological Verification Confidence: 0.99

1. Generic Name / āĻœā§‡āύ⧇āϰāĻŋāĻ• āύāĻžāĻŽ

Aceclofenac 100 mg — āĻāϏāĻŋāĻ•ā§āϞ⧋āĻĢ⧇āύāĻžāĻ•āĨ¤

2. Brand Name / āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ

Flexi 100 mg

Manufacturer: Square Pharmaceuticals PLC.

3. MedEx Alternative Brand / āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ

āĻāĻ•āχ generic-āĻāϰ āĻ•āϝāĻŧ⧇āĻ•āϟāĻŋ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ:

  • Acebid 100 mg
  • Acedol 100 mg
  • Acefenac 100 mg
  • Aceclof 100 mg

āĻāϏāĻŦ alternative brand āĻāĻ•āχ āϏāĻ™ā§āϗ⧇ āĻ—ā§āϰāĻšāϪ⧇āϰ āϜāĻ¨ā§āϝ āύāϝāĻŧāĨ¤

4. MedEx Therapeutic Class / āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻ—āϤ āĻļā§āϰ⧇āĻŖāĻŋ

Drugs for Osteoarthritis; Drugs used for Rheumatoid Arthritis; Non-steroidal Anti-inflammatory Drugs (NSAIDs).

āĻŦāĻžāĻ‚āϞāĻž: āĻ…āĻ¸ā§āĻĨāĻŋāϏāĻ¨ā§āϧāĻŋāϰ āĻ•ā§āώāϝāĻŧāϜāύāĻŋāϤ āϰ⧋āĻ—, āϰāĻŋāωāĻŽāĻžāϟāϝāĻŧ⧇āĻĄ āφāĻ°ā§āĻĨā§āϰāĻžāχāϟāĻŋāϏ āĻāĻŦāĻ‚ āĻŦā§āϝāĻĨāĻž-āĻĒā§āϰāĻĻāĻžāĻšā§‡āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϝāĻŧ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻ“āώ⧁āϧāĨ¤

5. Pharmacological Class / āĻĢāĻžāĻ°ā§āĻŽāĻžāϕ⧋āϞāϜāĻŋāĻ•ā§āϝāĻžāϞ āĻļā§āϰ⧇āĻŖāĻŋ

NSAID — Non-steroidal Anti-inflammatory Drug.

āĻŦāĻžāĻ‚āϞāĻž: āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄāĻŦāĻŋāĻšā§€āύ āĻĒā§āϰāĻĻāĻžāĻšāύāĻžāĻļāĻ• āĻ“ āĻŦā§āϝāĻĨāĻžāύāĻžāĻļāĻ•āĨ¤

6. Use/Purpose of Drug / āĻ“āώ⧁āϧ⧇āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ

Analgesic and Anti-inflammatory Action.

āĻŦāĻžāĻ‚āϞāĻž: āĻŦā§āϝāĻĨāĻž āĻ“ āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋āĨ¤

7. Why Doctor Prescribed This Drug / āϕ⧇āύ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻĻāĻŋāϝāĻŧ⧇āϛ⧇āύ?

āϏāĻŽā§āĻ­āĻŦāϤ āϰ⧋āĻ—ā§€āϰ Low Back Pain āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝāĨ¤

Aceclofenac-āĻāϰ approved indications-āĻāϰ āĻŽāĻ§ā§āϝ⧇ Lumbago — āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻž āϰāϝāĻŧ⧇āϛ⧇āĨ¤

Case-Specific Confidence: 0.88

8. Side Effects / āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž

Common: Dyspepsia, nausea, abdominal discomfort, dizzinessāĨ¤

Serious: Gastrointestinal bleeding, peptic ulceration, kidney injury, cardiovascular complicationsāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŦāĻĻāĻšāϜāĻŽ, āĻŦāĻŽāĻŋāĻ­āĻžāĻŦ, āĻĒ⧇āϟāĻŦā§āϝāĻĨāĻž, āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž, āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϤ⧇ āϰāĻ•ā§āϤāĻ•ā§āώāϰāĻŖ, āĻ•āĻŋāĻĄāύāĻŋāϰ āĻ•ā§āώāϤāĻŋ āĻāĻŦāĻ‚ āĻšā§ƒāĻĻā§â€Œāϰ⧋āĻ—āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻā§āρāĻ•āĻŋāĨ¤

9. MedEx Official Link

Flexi 100 mg — MedEx

10. Unit Price, Strip Price & Other Composition

ProductMedEx Price
Flexi 100 mgā§ŗ7.00/tablet
Flexi 100 mg — 10 tabletsā§ŗ70.00
Flexi SR 200 mgā§ŗ8.00/tablet
Flexi SR 200 mg — 10 tabletsā§ŗ80.00

Other Available Form: Sustained-release 200 mg tabletāĨ¤

Note: Flexi SR 200 mg āĻāĻŦāĻ‚ Flexi 100 mg-āĻāϰ dosing schedule āĻāĻ• āύāϝāĻŧāĨ¤

11. Mechanism of Action / āĻ•āĻžāĻ°ā§āϝāĻĒāĻĻā§āϧāϤāĻŋ

Aceclofenac inhibits cyclooxygenase enzymes and reduces prostaglandin synthesis.

āĻŦāĻžāĻ‚āϞāĻž: Cyclooxygenase enzyme-āĻāϰ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽ āĻ•āĻŽāĻŋāϝāĻŧ⧇ prostaglandin āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āĻ•āĻŽāĻžāϝāĻŧāĨ¤ āĻĢāϞ⧇ āĻŦā§āϝāĻĨāĻž āĻ“ āĻĒā§āϰāĻĻāĻžāĻš āĻšā§āϰāĻžāϏ āĻĒāĻžāϝāĻŧāĨ¤

12. Drug Indications / āϕ⧋āύ āϕ⧋āύ āϰ⧋āϗ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧ?

Osteoarthritis — āĻ…āĻ¸ā§āĻĨāĻŋāϏāĻ¨ā§āϧāĻŋāϰ āĻ•ā§āώāϝāĻŧāϜāύāĻŋāϤ āĻŦāĻžāϤāĨ¤

Rheumatoid Arthritis — āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āĻ…āĻŸā§‹āχāĻŽāĻŋāωāύ āĻŦāĻžāϤāĨ¤

Ankylosing Spondylitis — āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āϰ⧋āĻ—āĨ¤

Lumbago — āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāĨ¤

Dental Pain — āĻĻāĻžāρāϤ⧇āϰ āĻŦā§āϝāĻĨāĻžāĨ¤

Traumatic Pain — āφāϘāĻžāϤāϜāύāĻŋāϤ āĻŦā§āϝāĻĨāĻžāĨ¤

13. Drug Interaction + Contraindications

Interactions: Warfarin, other anticoagulants, methotrexate, lithium, diuretics, ACE inhibitors/ARBs āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ NSAIDsāĨ¤

Contraindications: Aceclofenac hypersensitivity, aspirin/NSAID-induced asthma-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āĻāĻŦāĻ‚ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ GI bleeding āĻŦāĻž āϗ⧁āϰ⧁āϤāϰ āĻ…āĻ™ā§āĻ—-āĻ…āĻ•āĻžāĻ°ā§āϝāĻ•āĻžāϰāĻŋāϤāĻžāϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāϝāĻŧ āĻŦā§āϝāĻŦāĻšāĻžāϰ āύāĻŋāώāĻŋāĻĻā§āϧ āĻŦāĻž āĻ…āύ⧁āĻĒāϝ⧁āĻ•ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

14. Precautions & Warnings

Peptic ulcer, chronic kidney disease, hypertension, heart failure, dehydration āĻ“ elderly patients-āĻ āĻŦāĻŋāĻļ⧇āώ āϏāϤāĻ°ā§āĻ•āϤāĻžāĨ¤

15. Dosage & Administration

MedEx Adult Reference Dose: 100 mg twice daily.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒā§āϰāĻžāĻĒā§āϤāĻŦāϝāĻŧāĻ¸ā§āĻ•āĻĻ⧇āϰ āϜāĻ¨ā§āϝ āϰ⧇āĻĢāĻžāϰ⧇āĻ¨ā§āϏ āĻŽāĻžāĻ¤ā§āϰāĻž āĻĻāĻŋāύ⧇ āĻĻ⧁āχāĻŦāĻžāϰ ā§§ā§Ļā§Ļ āĻŽāĻŋ.āĻ—ā§āϰāĻž.āĨ¤

āĻāϟāĻŋ āĻāχ āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāĻ•ā§ƒāϤ prescribed frequency āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϛ⧇ āύāĻžāĨ¤ āĻ¸ā§āĻŦāĻ˛ā§āĻĒāϤāĻŽ āϏāĻŽāϝāĻŧ⧇ āϏāĻ°ā§āĻŦāύāĻŋāĻŽā§āύ āĻ•āĻžāĻ°ā§āϝāĻ•āϰ dose āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

16. Pregnancy & Lactation

Pregnancy-āϤ⧇ aceclofenac āϏāĻžāϧāĻžāϰāĻŖāϤ āĻāĻĄāĻŧāĻžāύ⧋ āωāϚāĻŋāϤ, āĻŦāĻŋāĻļ⧇āώāϤ āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻžāϰ ⧍ā§Ļ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āĻĒāϰ āĻāĻŦāĻ‚ āϤ⧃āϤ⧀āϝāĻŧ trimester-āĻāĨ¤

Breastfeeding-āĻāϰ āϏāĻŽāϝāĻŧ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻ“āώ⧁āϧ āĻ“ risk–benefit āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Clinical Confidence: 0.99 — verified drug properties.


💊 DRUG 02 — SECLO 20 mg

Brand Identification Confidence: 0.91

MedEx Verification Confidence: 0.99

1. Generic Name

Omeprazole 20 mg — āĻ“āĻŽāĻŋāĻĒā§āϰāĻžāϜāϞāĨ¤

2. Brand Name

Seclo 20 mg EC Capsule

Manufacturer: Square Pharmaceuticals PLC.

3. MedEx Alternative Brand

āĻāĻ•āχ generic-āĻāϰ āωāĻĻāĻžāĻšāϰāĻŖ:

Seclogen, Losectil āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ omeprazole preparationsāĨ¤

4. MedEx Therapeutic Class

Proton Pump Inhibitor (PPI).

āĻŦāĻžāĻ‚āϞāĻž: āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āĻ…ā§āϝāĻžāϏāĻŋāĻĄ āύāĻŋāσāϏāϰāĻŖ āĻ•āĻŽāĻžāύ⧋āϰ āĻ“āώ⧁āϧāĨ¤

5. Pharmacological Class

Gastric Hâē/Kâē-ATPase Inhibitor.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ proton pump āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇ āĻ…ā§āϝāĻžāϏāĻŋāĻĄ āĻ•āĻŽāĻžāϝāĻŧāĨ¤

6. Use/Purpose of Drug

Acid Suppression and Gastroprotection.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āĻ…ā§āϝāĻžāϏāĻŋāĻĄ āĻ•āĻŽāĻžāύ⧋ āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ NSAID-associated ulcer āĻĒā§āϰāϤāĻŋāϰ⧋āϧāĨ¤

7. Why Doctor Prescribed This Drug

āϏāĻŽā§āĻ­āĻŦāϤ Flexi (Aceclofenac) āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āϏāĻ™ā§āϗ⧇ GI protection-āĻāϰ āϜāĻ¨ā§āϝāĨ¤

āϤāĻŦ⧇ āϰ⧋āĻ—ā§€āϰ āφāϗ⧇ āĻĨ⧇āϕ⧇ āĻ—ā§āϝāĻžāĻ¸ā§āĻŸā§āϰāĻŋāĻ• āφāϞāϏāĻžāϰ āφāĻ›ā§‡â€”āĻāĻŽāύ āϤāĻĨā§āϝ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤

Case-Specific Confidence: 0.86

8. Side Effects

Headache, nausea, diarrhea, abdominal pain āĻ“ constipationāĨ¤

āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ hypomagnesemia, vitamin B12 deficiency āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āĻā§āρāĻ•āĻŋ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

9. MedEx Official Link

Seclo 20 mg — MedEx

10. Unit Price, Strip Price & Other Composition

ProductPrice
Seclo 20 mgā§ŗ6.00/capsule
Seclo 20 mg — 10 capsulesā§ŗ60.00
Seclo 40 mgā§ŗ9.00/capsule
Seclo 40 mg/vialā§ŗ95.00
Seclo MUPS 20 mgā§ŗ7.00/tablet

11. Mechanism of Action

Omeprazole irreversibly inhibits the Hâē/Kâē-ATPase proton pump of gastric parietal cells.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ parietal cell-āĻāϰ proton pump āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇ gastric acid secretion āĻ•āĻŽāĻžāϝāĻŧāĨ¤

12. Drug Indications

Peptic Ulcer Disease — āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀ āĻŦāĻž āĻĄā§āĻ“āĻĄā§‡āύāĻžāĻŽā§‡āϰ āφāϞāϏāĻžāϰāĨ¤

GERD — āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āĻ…ā§āϝāĻžāϏāĻŋāĻĄ āĻ–āĻžāĻĻā§āϝāύāĻžāϞāĻŋāϤ⧇ āωāϠ⧇ āφāϏāĻžāĨ¤

NSAID-associated Ulcer — NSAID-āĻāϰ āĻ•āĻžāϰāϪ⧇ āφāϞāϏāĻžāϰāĨ¤

Acid-related Dyspepsia — āĻ…ā§āϝāĻžāϏāĻŋāĻĄāϜāύāĻŋāϤ āĻŦāĻĻāĻšāϜāĻŽāĨ¤

H. pylori Eradication Regimen — āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ antibiotic regimen-āĻāϰ āĻ…āĻ‚āĻļāĨ¤

Zollinger–Ellison Syndrome — āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ gastric acid secretion-āĻāϰ āĻŦāĻŋāϰāϞ āϰ⧋āĻ—āĨ¤

13. Drug Interaction + Contraindications

Interactions: Clopidogrel, warfarin, phenytoin, high-dose methotrexate āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ antiretroviral āĻŦāĻž antifungal medicineāĨ¤

Contraindications: Omeprazole hypersensitivity āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ contraindicated combinationsāĨ¤

14. Precautions & Warnings

āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻāĻŋ PPI therapy āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻĒāĻ°ā§āϝāĻžāϞ⧋āϚāύāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤ āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻ›āĻžāĻĄāĻŧāĻž āĻ…āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟāĻ•āĻžāϞ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻ āĻŋāĻ• āύāϝāĻŧāĨ¤

15. Dosage & Administration

MedEx Reference: 20 mg once daily for several acid-related indicationsāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ acid-related condition-āĻ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĻāĻŋāύ⧇ āĻāĻ•āĻŦāĻžāϰ ⧍ā§Ļ āĻŽāĻŋ.āĻ—ā§āϰāĻž. āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧāĨ¤

āĻĒā§āϰāĻ•ā§ƒāϤ indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ dose āĻ“ duration āĻ­āĻŋāĻ¨ā§āύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

16. Pregnancy & Lactation

āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻšāϞ⧇ āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻžāϝāĻŧ omeprazole āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝāĻžāϝāĻŧāĨ¤ Breastfeeding-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇āĻ“ āĻŦāĻ°ā§āϤāĻŽāĻžāύ clinical evidence āĻāĻŦāĻ‚ maternal indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ risk–benefit āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Clinical Confidence: 0.99


💊 DRUG 03 — RELENTUS 2 mg

Brand Identification Confidence: 0.83

MedEx Verification Confidence: 0.99

1. Generic Name

Tizanidine Hydrochloride — āϟāĻŋāϜāĻžāύāĻŋāĻĄāĻŋāύ āĻšāĻžāχāĻĄā§āϰ⧋āĻ•ā§āϞ⧋āϰāĻžāχāĻĄāĨ¤

2. Brand Name

Relentus 2 mg

Manufacturer: Beximco Pharmaceuticals Ltd.

3. MedEx Alternative Brand

  • Tizadin 2 mg
  • Tizalex 2 mg
  • Tizalud 2 mg
  • Tizan 2 mg
  • Sirdalud 2 mg

4. MedEx Therapeutic Class

Centrally Acting Skeletal Muscle Relaxants.

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧇āĻ¨ā§āĻĻā§āϰ⧀āϝāĻŧ āĻ¸ā§āύāĻžāϝāĻŧ⧁āϤāĻ¨ā§āĻ¤ā§āϰ⧇ āĻ•āĻžāϜ āĻ•āϰ⧇ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋ āĻļāĻŋāĻĨāĻŋāϞāĻ•āĻžāϰ⧀ āĻ“āώ⧁āϧāĨ¤

5. Pharmacological Class

Alpha-2 Adrenergic Receptor Agonist.

6. Use/Purpose of Drug

Reduction of Painful Muscle Spasm and Spasticity.

āĻŦāĻžāĻ‚āϞāĻž: āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ āĻŦā§āϝāĻĨāĻžāϝ⧁āĻ•ā§āϤ āϟāĻžāύ āĻŦāĻž āĻ–āĻŋāρāϚ⧁āύāĻŋ āĻ•āĻŽāĻžāύ⧋āĨ¤

7. Why Doctor Prescribed This Drug

āϏāĻŽā§āĻ­āĻŦāϤ āϕ⧋āĻŽāϰ⧇āϰ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ spasm āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻĻāĻŋāϝāĻŧ⧇āϛ⧇āύāĨ¤

āϤāĻŦ⧇ āϰ⧋āĻ—ā§€āϰ examination-āĻ spasm āĻĒāĻžāĻ“āϝāĻŧāĻž āϗ⧇āĻ›ā§‡â€”āĻāĻŽāύ āĻĒā§āϰāĻŽāĻžāĻŖ āύ⧇āχāĨ¤

Case-Specific Confidence: 0.74

8. Side Effects

Somnolence — āϘ⧁āĻŽāϘ⧁āĻŽ āĻ­āĻžāĻŦāĨ¤

Dizziness — āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāĨ¤

Dry Mouth — āĻŽā§āĻ– āĻļ⧁āĻ•āĻŋāϝāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

Hypotension — āϰāĻ•ā§āϤāϚāĻžāĻĒ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

Bradycardia — āĻšā§ƒāĻĻā§â€ŒāĻ¸ā§āĻĒāĻ¨ā§āĻĻāύ āϧ⧀āϰ āĻšāϝāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

Liver Enzyme Elevation — āϞāĻŋāĻ­āĻžāϰ⧇āϰ āĻāύāϜāĻžāχāĻŽ āĻŦ⧇āĻĄāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

9. MedEx Official Link

Relentus 2 mg — MedEx

10. Unit Price, Strip Price & Other Strengths

ProductPrice
Relentus 2 mgā§ŗ8.00/tablet
Relentus 2 mg — 10 tabletsā§ŗ80.00
Tizadin 2 mgā§ŗ5.04/tablet
Tizalex 2 mgā§ŗ5.00/tablet
Tizalud 2 mgā§ŗ5.02/tablet

Relentus āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄā§‡āϰ āĻ…āĻ¨ā§āϝ strength MedEx-āĻāϰ āωāĻ˛ā§āϞāĻŋāĻ–āĻŋāϤ profile-āĻ āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤

11. Mechanism of Action

Tizanidine stimulates presynaptic alpha-2 adrenergic receptors in the spinal cord and reduces excitatory neurotransmitter release.

āĻŦāĻžāĻ‚āϞāĻž: āĻŽā§‡āϰ⧁āϰāĻœā§āϜ⧁āϰ alpha-2 receptor āϏāĻ•ā§āϰāĻŋāϝāĻŧ āĻ•āϰ⧇ excitatory neurotransmitter āύāĻŋāσāϏāϰāĻŖ āĻ•āĻŽāĻžāϝāĻŧāĨ¤ āĻĢāϞ⧇ muscle tone āĻ“ spasm āĻ•āĻŽāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

12. Drug Indications

Painful Muscle Spasm — āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ āĻŦā§āϝāĻĨāĻžāϝ⧁āĻ•ā§āϤ āĻ–āĻŋāρāϚ⧁āύāĻŋāĨ¤

Cervical/Lumbar Syndromes — āϘāĻžāĻĄāĻŧ āĻ“ āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ musculoskeletal syndromesāĨ¤

Spasticity Associated with Multiple Sclerosis — MS-āϜāύāĻŋāϤ āĻĒ⧇āĻļāĻŋāϰ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻļāĻ•ā§āϤ āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āĻžāĨ¤

Spasticity in Selected Neurological Disorders — āĻ•āĻŋāϛ⧁ āĻ¸ā§āύāĻžāϝāĻŧāĻŦāĻŋāĻ• āϰ⧋āϗ⧇ spasticityāĨ¤

13. Drug Interaction + Contraindications

Major Contraindicated Drug Combinations:

Ciprofloxacin āĻāĻŦāĻ‚ fluvoxamineāĨ¤

Other Interactions: Alcohol, sedatives, antihypertensives āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ CNS depressantsāĨ¤

Contraindications: Severe hepatic impairment, hypersensitivity āĻāĻŦāĻ‚ contraindicated CYP1A2 inhibitor combinationsāĨ¤

14. Precautions & Warnings

Sedation, hypotension, falls āĻāĻŦāĻ‚ liver injury-āĻāϰ āĻā§āρāĻ•āĻŋ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϏāϤāĻ°ā§āĻ• āĻĨāĻžāĻ•āϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻ“āώ⧁āϧ āϏ⧇āĻŦāύ⧇āϰ āĻĒāϰ⧇ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻŦāĻž āϘ⧁āĻŽāϘ⧁āĻŽ āĻ­āĻžāĻŦ āĻšāϞ⧇ āĻ—āĻžāĻĄāĻŧāĻŋ āϚāĻžāϞāĻžāύ⧋ āĻŦāĻž āĻā§āρāĻ•āĻŋāĻĒā§‚āĻ°ā§āĻŖ āϝāĻ¨ā§āĻ¤ā§āϰ āĻĒāϰāĻŋāϚāĻžāϞāύāĻž āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

15. Dosage & Administration

MedEx Reference Dose: Painful muscle spasm-āĻāϰ āϜāĻ¨ā§āϝ 2–4 mg, āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĻāĻŋāύ⧇ āϤāĻŋāύāĻŦāĻžāϰ āĻĒāĻ°ā§āϝāĻ¨ā§āϤ; treatment individualizedāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϰ⧋āĻ—ā§€āϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻ•āĻŽ āĻŽāĻžāĻ¤ā§āϰāĻžāϝāĻŧ āĻļ⧁āϰ⧁ āĻ•āϰ⧇ dose āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻšāĻžāϤ⧇āϰ āϞ⧇āĻ–āĻž āĻĨ⧇āϕ⧇ āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāĻ•ā§ƒāϤ dose/frequency āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧāĨ¤

16. Pregnancy & Lactation

Pregnancy āĻ“ breastfeeding-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āύāĻŋāϰāĻžāĻĒāĻ¤ā§āϤāĻžāϰ āϤāĻĨā§āϝ āϏ⧀āĻŽāĻŋāϤāĨ¤ āĻ¸ā§āĻĒāĻˇā§āϟ āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻ›āĻžāĻĄāĻŧāĻž āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāĻĄāĻŧāĻžāύ⧋ āωāϚāĻŋāϤāĨ¤

Guideline Caution: WHO 2023 guideline āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ chronic primary low back pain-āĻ skeletal muscle relaxants routine treatment āĻšāĻŋāϏ⧇āĻŦ⧇ āϏ⧁āĻĒāĻžāϰāĻŋāĻļāĻ•ā§ƒāϤ āύāϝāĻŧāĨ¤


💊 DRUG 04 — SANTE ✅ (CORRECTED)

SANTE — Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C

Brand Identification Confidence: 1.00 — āφāĻĒāύāĻžāϰ āϏāĻ‚āĻļā§‹āϧāύ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€āĨ¤

MedEx Pharmacological Verification Confidence: 0.99

1. Generic Name / āĻœā§‡āύ⧇āϰāĻŋāĻ• āύāĻžāĻŽ

Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C

āĻŦāĻžāĻ‚āϞāĻž:

āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻ˛ā§āϝāĻžāĻ•āĻŸā§‡āϟ āĻ—ā§āϞ⧁āϕ⧋āύ⧇āϟ + āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻ•āĻžāĻ°ā§āĻŦā§‹āύ⧇āϟ + āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āϏāĻŋāĨ¤

Composition / āωāĻĒāĻžāĻĻāĻžāύ

āĻĒā§āϰāϤāĻŋ effervescent tablet-āĻ āϰāϝāĻŧ⧇āϛ⧇:

IngredientQuantityāĻŦāĻžāĻ‚āϞāĻž
Calcium Lactate Gluconate1000 mgāĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽā§‡āϰ āĻāĻ•āϟāĻŋ āϞāĻŦāĻŖ
Calcium Carbonate327 mgāĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽā§‡āϰ āφāϰ⧇āĻ•āϟāĻŋ āϞāĻŦāĻŖ
Vitamin C (Ascorbic Acid)500 mgāĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āϏāĻŋ

Important: 1000 mg āĻ“ 327 mg āĻšāϞ⧋ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ calcium salt-āĻāϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖ; āĻāϗ⧁āϞ⧋āϕ⧇ āϏāϰāĻžāϏāϰāĻŋ 1327 mg elemental calcium āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ—āĻŖāύāĻž āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Vitamin D3: Not included — āύ⧇āχāĨ¤

2. Brand Name / āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ

Sante Effervescent Tablet

Manufacturer: Healthcare Pharmaceuticals Ltd., Bangladesh.

3. MedEx Alternative Brand / āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ

āĻāĻ•āχ generic combination-āĻāϰ āĻ•āϝāĻŧ⧇āĻ•āϟāĻŋ MedEx-listed alternative:

Alternative BrandCompanyUnit Price
Calbo-CSquare Pharmaceuticalsā§ŗ13.00
Cavic-CIncepta Pharmaceuticalsā§ŗ13.00
Calfix COSL Pharmaā§ŗ10.00
Ostogen COpsonin Pharmaā§ŗ12.00
CalceferRenataā§ŗ10.00
Acical-CACIā§ŗ15.00

āĻāĻ•āχ active ingredient combination āĻ“ equivalent formulation āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰ⧇ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻŦ⧇āϛ⧇ āύāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤

4. MedEx Therapeutic Class / āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻ—āϤ āĻļā§āϰ⧇āĻŖāĻŋ

Specific Mineral & Vitamin Combined Preparations.

āĻŦāĻžāĻ‚āϞāĻž: āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ–āύāĻŋāϜ āĻ“ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ⧇āϰ āϏāĻŽāĻ¨ā§āĻŦāĻŋāϤ āϏāĻŽā§āĻĒā§‚āϰāĻ•āĨ¤

5. Pharmacological Class / āĻĢāĻžāĻ°ā§āĻŽāĻžāϕ⧋āϞāϜāĻŋāĻ•ā§āϝāĻžāϞ āĻļā§āϰ⧇āĻŖāĻŋ

Calcium Supplement + Water-Soluble Vitamin Supplement.

āĻŦāĻžāĻ‚āϞāĻž: āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻ“ āĻĒāĻžāύāĻŋāϤ⧇ āĻĻā§āϰāĻŦāĻŖā§€āϝāĻŧ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ⧇āϰ āϏāĻŽā§āĻĒā§‚āϰāĻ•āĨ¤

6. Use/Purpose of Drug / āĻ“āώ⧁āϧ⧇āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ

Sante-āĻāϰ āĻĒā§āϰāϧāĻžāύ āωāĻĻā§āĻĻ⧇āĻļā§āϝ:

Calcium Supplementation — āĻļāϰ⧀āϰ⧇ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽā§‡āϰ āϘāĻžāϟāϤāĻŋ āĻĒā§‚āϰāĻŖāĨ¤

Vitamin C Supplementation — āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ C-āĻāϰ āϘāĻžāϟāϤāĻŋ āĻĒā§‚āϰāĻŖāĨ¤

Support of Bone Mineral Metabolism — āĻšāĻžāĻĄāĻŧ⧇āϰ āĻ–āύāĻŋāĻœā§‡āϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻŦāĻŋāĻĒāĻžāϕ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻžāĨ¤

Correction of Nutritional Deficiency — āĻĒ⧁āĻˇā§āϟāĻŋāĻ—āϤ āϘāĻžāϟāϤāĻŋāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

āĻāϟāĻŋ āϏāϰāĻžāϏāϰāĻŋ āĻŦā§āϝāĻĨāĻžāύāĻžāĻļāĻ• āĻ“āώ⧁āϧ āύāϝāĻŧāĨ¤

7. Why Doctor Prescribed Sante in This Patient / āĻāχ āϰ⧋āĻ—ā§€āϕ⧇ āϕ⧇āύ Sante āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇āϛ⧇?

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ LBP-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻ˛ā§āϞ⧇āĻ–, analgesic āĻāĻŦāĻ‚ muscle relaxant-āĻāϰ āϏāĻ™ā§āϗ⧇ Sante āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

āĻāĻ–āĻžāύ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻšāϤ⧇ āĻĒāĻžāϰ⧇:

A. Suspected Calcium Insufficiency — āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽā§‡āϰ āĻ…āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤāϤāĻž āϏāĻ¨ā§āĻĻ⧇āĻšāĨ¤

āϰ⧋āĻ—ā§€āϰ āĻ–āĻžāĻĻā§āϝāĻžāĻ­ā§āϝāĻžāϏ āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ clinical āϤāĻĨā§āϝ⧇āϰ āĻ­āĻŋāĻ¤ā§āϤāĻŋāϤ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• calcium supplementation āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

B. Nutritional Supplementation — āĻĒ⧁āĻˇā§āϟāĻŋāĻ—āϤ āϏāĻšāĻžāϝāĻŧāϤāĻžāĨ¤

āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻ“ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ C-āĻāϰ āϚāĻžāĻšāĻŋāĻĻāĻž āĻĒā§‚āϰāϪ⧇āϰ āϜāĻ¨ā§āϝāĨ¤

C. Supportive Bone Health Management — āĻšāĻžāĻĄāĻŧ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āϰāĻ•ā§āώāĻžāϝāĻŧ āϏāĻšāĻžāϝāĻŧāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ metabolic bone disorder āĻĨāĻžāĻ•āϞ⧇ supplementation āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Critical Clinical Interpretation

Sante prescribing does not establish a diagnosis of osteoporosis, osteomalacia or calcium deficiency.

āĻŦāĻžāĻ‚āϞāĻž: āĻļ⧁āϧ⧁ Sante āĻĻ⧇āĻ“āϝāĻŧāĻžāϰ āĻ•āĻžāϰāϪ⧇ āϰ⧋āĻ—ā§€āϰ osteoporosis, osteomalacia āĻŦāĻž calcium deficiency āφāĻ›ā§‡â€”āĻāĻŽāύ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āύ⧇āĻ“āϝāĻŧāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Sante is not an evidence-based primary analgesic treatment for nonspecific low back pain.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻžāϧāĻžāϰāĻŖ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāϰ āĻĒā§āϰāϧāĻžāύ āĻŦā§āϝāĻĨāĻžāύāĻžāĻļāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻšāĻŋāϏ⧇āĻŦ⧇ Sante āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻžāϰ āϏ⧁āĻ¸ā§āĻĒāĻˇā§āϟ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž āύ⧇āχāĨ¤

Patient-Specific Rationale Confidence: 0.58 — supplementation-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ, āĻ•āĻŋāĻ¨ā§āϤ⧁ āϰ⧋āĻ—ā§€āϰ calcium deficiency āĻŦāĻž osteoporosis-āĻāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āύ⧇āχāĨ¤

8. Side Effects / āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž

Common/Occasional:

Abdominal Bloating — āĻĒ⧇āϟ āĻĢāĻžāρāĻĒāĻžāĨ¤

Diarrhea — āĻĒāĻžāϤāϞāĻž āĻĒāĻžāϝāĻŧāĻ–āĻžāύāĻžāĨ¤

Gastrointestinal Discomfort — āĻĒ⧇āĻŸā§‡ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋāĨ¤

Important Risks:

Hypercalcemia — āϰāĻ•ā§āϤ⧇ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻŦ⧇āĻĄāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

Hypercalciuria — āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻŦ⧇āϰ āĻšāĻ“āϝāĻŧāĻžāĨ¤

Renal Calculi — āĻ•āĻŋāĻĄāύāĻŋāϤ⧇ āĻĒāĻžāĻĨāϰāĨ¤

āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰāϞ⧇ āĻĒā§‚āĻ°ā§āĻŦāĻĒā§āϰāĻŦāĻŖāϤāĻžāϏāĻŽā§āĻĒāĻ¨ā§āύ āϰ⧋āĻ—ā§€āϰ āĻāϏāĻŦ āĻā§āρāĻ•āĻŋ āĻŦāĻžāĻĄāĻŧāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

9. MedEx Official Link

Sante Effervescent Tablet — MedEx Official Drug Profile

10. Unit Price, Strip Price & Available Composition

ProductPrice
Sante Effervescent Tablet — 1 tabletā§ŗ15.00
Sante — 10 tabletsā§ŗ150.00
Pack1 × 10 effervescent tablets
ManufacturerHealthcare Pharmaceuticals Ltd.

Note: MedEx-āĻāϰ āϤāĻžāϞāĻŋāĻ•āĻžāϝāĻŧ ā§ŗ150.00-āϕ⧇ Strip Price āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻ⧇āĻ–āĻžāύ⧋ āĻšāϞ⧇āĻ“ āĻāϟāĻŋ effervescent tablet-āĻāϰ ā§§ā§ĻāϟāĻŋāϰ āĻĒā§āϝāĻžāĻ•, āϏāĻžāϧāĻžāϰāĻŖ tablet blister strip āύāϝāĻŧāĨ¤

Available as Other Composition

Sante-āĻāϰ āĻ…āĻ¨ā§āϝ strength āĻŦāĻž Vitamin D-containing Sante formulation āĻāχ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ MedEx profile-āĻ āϤāĻžāϞāĻŋāĻ•āĻžāϭ⧁āĻ•ā§āϤ āύ⧇āχāĨ¤

āϤāĻŦ⧇ āĻāĻ•āχ calcium salt-āĻāϰ āϏāĻ™ā§āϗ⧇ Vitamin D3 āϝ⧁āĻ•ā§āϤ āĻ…āĻ¨ā§āϝ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄā§‡āϰ combination āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāĨ¤ āĻāϗ⧁āϞ⧋ Sante-āĻāϰ āϏāϰāĻžāϏāϰāĻŋ equivalent āύāϝāĻŧāĨ¤

11. Mechanism of Action / āĻ“āώ⧁āϧ⧇āϰ āĻ•āĻžāĻ°ā§āϝāĻĒāĻĻā§āϧāϤāĻŋ

A. Calcium Lactate Gluconate

āĻāϟāĻŋ āĻļāϰ⧀āϰ⧇ calcium āϏāϰāĻŦāϰāĻžāĻš āĻ•āϰ⧇āĨ¤

Calcium normal nerve conduction, muscle contraction, cardiac function āĻāĻŦāĻ‚ bone mineralization-āĻāϰ āϜāĻ¨ā§āϝ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻ¸ā§āύāĻžāϝāĻŧ⧁, āĻĒ⧇āĻļāĻŋ, āĻšā§ƒāĻĻā§â€ŒāϝāĻ¨ā§āĻ¤ā§āϰ āĻ“ āĻšāĻžāĻĄāĻŧ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ•āĻžāĻœā§‡āϰ āϜāĻ¨ā§āϝ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

B. Calcium Carbonate

āĻāϟāĻŋ calcium-āĻāϰ āĻāĻ•āϟāĻŋ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ‰ā§ŽāϏāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻ–āĻžāĻĻā§āϝ āĻŦāĻž āĻ“āώ⧁āϧ⧇āϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āϏāϰāĻŦāϰāĻžāĻš āĻ•āϰ⧇ āĻļāϰ⧀āϰ⧇āϰ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ calcium balance āĻŦāϜāĻžāϝāĻŧ āϰāĻžāĻ–āϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤

C. Vitamin C

Vitamin C collagen synthesis-āĻāϰ āϜāĻ¨ā§āϝ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ cofactorāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: Collagen āϤ⧈āϰāĻŋāϤ⧇ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ C āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤ Collagen āĻšāĻžāĻĄāĻŧ, āϞāĻŋāĻ—āĻžāĻŽā§‡āĻ¨ā§āϟ, āĻ¤ā§āĻŦāĻ• āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ connective tissue-āĻāϰ āĻ—āĻ āύāĻ—āϤ āωāĻĒāĻžāĻĻāĻžāύāĨ¤

12. Drug Indications / āϕ⧋āύ āϕ⧋āύ āϰ⧋āϗ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧ?

1. Calcium Deficiency — āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽā§‡āϰ āϘāĻžāϟāϤāĻŋāĨ¤

2. Vitamin C Deficiency — āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ C-āĻāϰ āϘāĻžāϟāϤāĻŋāĨ¤

3. Osteoporosis — āĻšāĻžāĻĄāĻŧ⧇āϰ āϘāύāĻ¤ā§āĻŦ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻž, āϝ⧇āĻ–āĻžāύ⧇ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ calcium intake āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āϏāĻšāĻžāϝāĻŧāĻ• āĻ…āĻ‚āĻļ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

4. Increased Calcium Requirement — āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽā§‡āϰ āϚāĻžāĻšāĻŋāĻĻāĻž āĻŦ⧃āĻĻā§āϧāĻŋ, āϝ⧇āĻŽāύ āĻ•āĻŋāϛ⧁ āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻž, āĻ¸ā§āϤāĻ¨ā§āϝāĻĻāĻžāύ āĻŦāĻž āĻŦ⧃āĻĻā§āϧ āĻŦāϝāĻŧāϏ⧇āϰ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋāĨ¤

5. Nutritional Deficiency During Recovery — āĻ…āϏ⧁āĻ¸ā§āĻĨāϤāĻžāϰ āĻĒāϰ āĻĒ⧁āĻˇā§āϟāĻŋāĻ—āϤ āϘāĻžāϟāϤāĻŋāĨ¤

6. Postmenopausal Nutritional Support — āĻŽā§‡āύ⧋āĻĒāϜ-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻĒ⧁āĻˇā§āϟāĻŋāĻ—āϤ āϏāĻšāĻžāϝāĻŧāϤāĻžāĨ¤

13. Drug Interaction + Contraindications

Drug Interactions

Tetracycline Antibiotics: āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ antibiotic absorption āĻ•āĻŽāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Digoxin: Calcium imbalance āĻĨāĻžāĻ•āϞ⧇ cardiac toxicity-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤

Thiazide Diuretics: Hypercalcemia-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻžāĻĄāĻŧāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Levothyroxine: Calcium levothyroxine-āĻāϰ āĻļā§‹āώāĻŖ āĻ•āĻŽāĻžāϝāĻŧ; āϏāĻžāϧāĻžāϰāĻŖāϤ āφāϞāĻžāĻĻāĻž āϏāĻŽāϝāĻŧ⧇ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤

Iron Supplement: Calcium āĻ•āĻŋāϛ⧁ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋāϤ⧇ iron absorption-āĻ āĻĒā§āϰāĻ­āĻžāĻŦ āĻĢ⧇āϞāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Contraindications

Hypercalcemia — āϰāĻ•ā§āϤ⧇ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽāĨ¤

Severe Hypercalciuria — āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽāĨ¤

Severe Renal Failure — āϗ⧁āϰ⧁āϤāϰ āĻ•āĻŋāĻĄāύāĻŋ āĻ…āĻ•āĻžāĻ°ā§āϝāĻ•āĻžāϰāĻŋāϤāĻžāĨ¤

Certain Disorders of Calcium Metabolism — āĻ•ā§āϝāĻžāϞāϏāĻŋāϝāĻŧāĻžāĻŽ āĻŦāĻŋāĻĒāĻžāϕ⧇āϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϰ⧋āĻ—āĨ¤

14. Precautions & Warnings

āĻ•āĻŋāĻĄāύāĻŋāϤ⧇ āĻĒāĻžāĻĨāϰ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ, renal impairment, hypercalcemia-āĻāϰ āĻā§āρāĻ•āĻŋ āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝ calcium-containing supplement āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻŦāĻŋāώāϝāĻŧ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āϝāĻžāĻĻ⧇āϰ āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏ āϰāϝāĻŧ⧇āϛ⧇ āϤāĻžāĻĻ⧇āϰ effervescent formulation-āĻāϰ excipients āĻ“ sugar content āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

15. Dosage & Administration

MedEx Adult Reference Dose:

1 effervescent tablet once daily.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒā§āϰāĻžāĻĒā§āϤāĻŦāϝāĻŧāĻ¸ā§āĻ•āĻĻ⧇āϰ āϜāĻ¨ā§āϝ āϰ⧇āĻĢāĻžāϰ⧇āĻ¨ā§āϏ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āĻĻāĻŋāύ⧇ āĻāĻ•āϟāĻŋ effervescent tabletāĨ¤

Administration: Dissolve one tablet completely in a glass of water before drinking.

āĻŦāĻžāĻ‚āϞāĻž: āĻāĻ•āϟāĻŋ āĻŸā§āϝāĻžāĻŦāϞ⧇āϟ āĻāĻ• āĻ—ā§āϞāĻžāϏ āĻĒāĻžāύāĻŋāϤ⧇ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āϗ⧁āϞāĻŋāϝāĻŧ⧇ āĻĒāĻžāύ āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤

āϖ⧁āĻŦ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ: āϏāĻžāϧāĻžāϰāĻŖ āĻŸā§āϝāĻžāĻŦāϞ⧇āĻŸā§‡āϰ āĻŽāϤ⧋ āϏāϰāĻžāϏāϰāĻŋ āĻ—āĻŋāϞ⧇ āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āϜāĻ¨ā§āϝ āĻāϟāĻŋ āϤ⧈āϰāĻŋ āύāϝāĻŧāĨ¤

16. Pregnancy & Lactation

Calcium āĻ“ Vitamin C āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻŽāĻžāĻ¤ā§āϰāĻžāϝāĻŧ āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻž āĻāĻŦāĻ‚ āĻ¸ā§āϤāĻ¨ā§āϝāĻĻāĻžāύ⧇āϰ āϏāĻŽāϝāĻŧ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āĻĒ⧁āĻˇā§āϟāĻŋ āωāĻĒāĻžāĻĻāĻžāύāĨ¤

āϤāĻŦ⧇ supplements āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āφāϗ⧇ āĻŽā§‹āϟ āĻĻ⧈āύāĻŋāĻ• calcium āĻ“ vitamin C intake, āĻ–āĻžāĻĻā§āϝāĻžāĻ­ā§āϝāĻžāϏ āĻāĻŦāĻ‚ renal risk āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

Pregnancy: Clinically indicated āĻšāϞ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Lactation: āωāĻĒāϝ⧁āĻ•ā§āϤ nutritional requirement āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝāĻžāϝāĻŧāĨ¤

MedEx Verification Confidence: 0.99


🩷 SECTION 08 | BANGLADESH DOCTORS’ DRUG LIST — MEDEX āĻ…āύ⧁āϝāĻžāϝāĻŧā§€

Low Back Pain-āĻ āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• āĻ“āώ⧁āϧ⧇āϰ āϤāĻžāϞāĻŋāĻ•āĻž

Clinical Note: āύāĻŋāĻšā§‡āϰ āϤāĻžāϞāĻŋāĻ•āĻž āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧ āĻāĻŽāύ āĻ“āώ⧁āϧ⧇āϰ āωāĻĻāĻžāĻšāϰāĻŖāĨ¤ āϏāĻŦ āĻ“āώ⧁āϧ āĻāĻ•āχ āϰ⧋āĻ—ā§€āϕ⧇ āĻĻāĻŋāϤ⧇ āĻšāĻŦā§‡â€”āĻāĻŽāύ āύāϝāĻŧāĨ¤ āĻ“āώ⧁āϧ āĻŦāĻžāĻ›āĻžāχ āύāĻŋāĻ°ā§āĻ­āϰ āĻ•āϰ⧇ āϰ⧋āϗ⧇āϰ āϧāϰāύ, clinical indication āĻ“ āĻā§āρāĻ•āĻŋāϰ āĻ“āĻĒāϰāĨ¤

No.GenericBangladesh BrandMedEx Therapeutic ClassUnit Price10-Unit PriceClinical Purpose
1Aceclofenac 100 mgFlexiNSAIDs; Drugs for OA/RAā§ŗ7.00ā§ŗ70.00Pain/inflammation — āĻŦā§āϝāĻĨāĻž āĻ“ āĻĒā§āϰāĻĻāĻžāĻš
2Naproxen Sodium 250 mgNaproxNSAIDsā§ŗ7.00ā§ŗ70.00Alternative NSAID
3Etoricoxib 90 mgEtorixSelective COX-2 Inhibitors / NSAIDsā§ŗ12.00ā§ŗ120.00Selected approved inflammatory pain indications
4Paracetamol 500 mgNapaNon-opioid Analgesic & Antipyreticā§ŗ1.20ā§ŗ12.00Analgesic; not recommended alone for nonspecific LBP
5Tizanidine 2 mgRelentusCentrally Acting Skeletal Muscle Relaxantsā§ŗ8.00ā§ŗ80.00Selected painful muscle spasm
6Omeprazole 20 mgSecloProton Pump Inhibitorā§ŗ6.00ā§ŗ60.00Selected GI protection
7Calcium Lactate Gluconate + Calcium Carbonate + Vitamin CSanteSpecific Mineral & Vitamin Combined Preparationsā§ŗ15.00ā§ŗ150.00Calcium/Vitamin C supplementation

Pricing: MedEx-listed unit āĻ“ pack prices; āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻĢāĻžāĻ°ā§āĻŽā§‡āϏāĻŋāϤ⧇ āĻŽā§‚āĻ˛ā§āϝ āĻ“ availability āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Key Clinical Drug Selection Principles

NSAID: Selected uncomplicated LBP-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ pharmacological option āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦāĻŋāĻŦ⧇āĻšā§āϝāĨ¤

Muscle Relaxant: Routine treatment āύāϝāĻŧ; āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ painful spasm āĻĨāĻžāĻ•āϞ⧇ āĻ¸ā§āĻŦāĻ˛ā§āĻĒāĻŽā§‡āϝāĻŧāĻžāĻĻāĻŋ risk–benefit assessment āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

PPI: NSAID-associated GI risk āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤

Sante: Calcium/Vitamin C supplementation-āĻāϰ āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻĨāĻžāĻ•āϞ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰāĨ¤ āϏāĻžāϧāĻžāϰāĻŖ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāϰ āϜāĻ¨ā§āϝ āύāĻŋāĻœā§‡ āĻĨ⧇āϕ⧇ āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āύāϝāĻŧāĨ¤

Etoricoxib: āĻ›āĻŦāĻŋāϰ āϰ⧋āĻ—ā§€āϰ nonspecific LBP-āĻāϰ āϜāĻ¨ā§āϝ āύāĻŋāϝāĻŧāĻŽāĻŋāϤ first-line medicine āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻ⧇āĻ–āĻžāύ⧋ āωāϚāĻŋāϤ āύāϝāĻŧ; āĻ…āύ⧁āĻŽā§‹āĻĻāĻŋāϤ indication āĻ“ cardiovascular risk āĻ…āύ⧁āϏāĻžāϰ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤

Avoid Duplicate NSAIDs: Flexi + Naprox + Etorix āĻāĻ•āχ āϏāĻ™ā§āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āωāϚāĻŋāϤ āύāϝāĻŧāĨ¤

Guideline Confidence: 0.97


🟨 SECTION 09 | MY CLINICAL WORKING ASSESSMENT / āφāĻŽāĻžāϰ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ

đŸŸĒ A. Provisional Diagnosis / āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ

Primary Working Diagnosis

Low Back Pain (LBP), Etiology Undetermined.

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻž, āϝāĻžāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻžāϰāĻŖ āĻāĻ–āύ⧋ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āύāϝāĻŧāĨ¤

Possible Underlying Condition

Suspected Nonspecific Mechanical Low Back Pain with Possible Lumbar Muscle Spasm.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋ āĻŦāĻž āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāϪ⧇ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻž, āϝāĻžāϰ āϏāĻ™ā§āϗ⧇ āĻĒ⧇āĻļāĻŋāϰ āϟāĻžāύ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Important Differential to Exclude if Indicated

Lumbar Radiculopathy — āϕ⧋āĻŽāϰ⧇āϰ āĻ¸ā§āύāĻžāϝāĻŧ⧁āĻŽā§‚āϞ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻ“āϝāĻŧāĻžāĨ¤

āĻĒāĻžāϝāĻŧ⧇ āĻ›āĻĄāĻŧāĻžāύ⧋ āĻŦā§āϝāĻĨāĻž, āĻāĻŋāύāĻāĻŋāύāĻŋ, āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻŦāĻž āĻĒ⧇āĻļāĻŋāϰ āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž āĻĨāĻžāĻ•āϞ⧇ āĻāχ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Why This Diagnosis?

Clinical Evidence 01: Prescribed notation probably indicates LBP.

Clinical Evidence 02: Flexi is used for pain and inflammation, including lumbago.

Clinical Evidence 03: Relentus may have been prescribed for suspected painful muscle spasm.

Clinical Evidence 04: Seclo may have been prescribed for gastroprotection with NSAID use.

Clinical Evidence 05: Sante suggests a possible supplementation plan, not a definitive diagnosis of metabolic bone disease.

Interpretation

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϤāĻĨā§āϝ symptom-level diagnosis āϏāĻŽāĻ°ā§āĻĨāύ āĻ•āϰ⧇āĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ āϕ⧋āύ⧋ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ structural spinal disease āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻžāϰ āĻŽāϤ⧋ clinical evidence āύ⧇āχāĨ¤

Provisional Diagnosis Confidence: 0.78


đŸŸĒ B. Specialist Referral / āϕ⧋āύ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžā§‡āϰ āĻ•āĻžāϛ⧇ āĻĒāĻžāĻ āĻžāϤ⧇ āĻšāĻŦ⧇?

First Choice

Orthopedics Specialist — āĻ…āĻ°ā§āĻĨā§‹āĻĒ⧇āĻĄāĻŋāĻ•ā§āϏ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĨ¤

Alternative

Physical Medicine & Rehabilitation Specialist — āĻĢāĻŋāϜāĻŋāĻ•ā§āϝāĻžāϞ āĻŽā§‡āĻĄāĻŋāϏāĻŋāύ āĻ“ āĻĒ⧁āύāĻ°ā§āĻŦāĻžāϏāύ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĨ¤

āĻŦā§āϝāĻĨāĻžāϰ āϏāĻ™ā§āϗ⧇ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āώāĻŽāϤāĻžāϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻĨāĻžāĻ•āϞ⧇ exercise-based rehabilitation āĻĒāϰāĻŋāĻ•āĻ˛ā§āĻĒāύāĻžāϰ āϜāĻ¨ā§āϝ āωāĻĒāϝ⧋āĻ—ā§€āĨ¤

Emergency Referral

āύāϤ⧁āύ bladder dysfunction, saddle anesthesia āĻŦāĻž progressive neurological weakness āĻĨāĻžāĻ•āϞ⧇ āϜāϰ⧁āϰāĻŋ spinal/neurosurgical assessment āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Referral Confidence: 0.97


🟧 C. Diagnostic Conclusion / āĻšā§‚āĻĄāĻŧāĻžāĻ¨ā§āϤ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ

Most Defensible Prescription-Based Working Diagnosis:

Low Back Pain (LBP), Etiology Undetermined — Suspected Mechanical Origin, Possible Associated Muscle Spasm.

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāϰāĻŖ āĻāĻ–āύ⧋ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āύāϝāĻŧ āĻāĻŽāύ āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇āϰ āĻŦā§āϝāĻĨāĻž; āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāĻŖ āĻ“ āĻĒ⧇āĻļāĻŋāϰ āϟāĻžāύ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Does Sante Change the Diagnosis?

No.

Sante āϝ⧁āĻ•ā§āϤ āĻšāĻ“āϝāĻŧāĻžāϰ āĻĢāϞ⧇ prescription interpretation-āĻ possible calcium/vitamin C supplementation āĻ…āĻ¨ā§āϤāĻ°ā§āϭ⧁āĻ•ā§āϤ āĻšāĻšā§āϛ⧇āĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ osteoporosis, calcium deficiency āĻŦāĻž osteomalacia-āĻāϰ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ āĻ•āϰāĻžāϰ āϝāĻĨ⧇āĻˇā§āϟ āĻĒā§āϰāĻŽāĻžāĻŖ āϤ⧈āϰāĻŋ āĻšāĻšā§āϛ⧇ āύāĻžāĨ¤

Diagnostic Conclusion Confidence: 0.89


đŸŸĸ SECTION 10 | Definition, Etiology & Pathophysiology / āϏāĻ‚āĻœā§āĻžāĻž, āĻ•āĻžāϰāĻŖ āĻ“ āϰ⧋āϗ⧇āϰ āĻ•āĻžāĻ°ā§āϝāĻĒāĻĻā§āϧāϤāĻŋ

10.1 Definition — āϏāĻ‚āĻœā§āĻžāĻž

Low Back Pain āĻšāϞ⧋ āĻĒāĻŋāϠ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻž āĻŦāĻž āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ, āϝāĻž āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋ, āϞāĻŋāĻ—āĻžāĻŽā§‡āĻ¨ā§āϟ, āĻĄāĻŋāĻ¸ā§āĻ•, āĻ…āĻ¸ā§āĻĨāĻŋāϏāĻ¨ā§āϧāĻŋ āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ pain-sensitive structure āĻĨ⧇āϕ⧇ āĻ‰ā§ŽāĻĒāĻ¨ā§āύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

10.2 Etiology — āĻ•āĻžāϰāĻŖ

Mechanical Causes / āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāĻŖ

Lumbar Muscle Strain: āϕ⧋āĻŽāϰ⧇āϰ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϤ⧇ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āϟāĻžāύ āĻŦāĻž āφāϘāĻžāϤāĨ¤

Ligament Sprain: āϕ⧋āĻŽāϰ⧇āϰ ligament āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻšāĻ“āϝāĻŧāĻžāĨ¤

Nonspecific Musculoskeletal Pain: āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϕ⧋āύ⧋ structural lesion āĻļāύāĻžāĻ•ā§āϤ āύāĻž āĻšāϞ⧇āĻ“ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāĨ¤

Degenerative Changes: āĻŦāϝāĻŧāϏ āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ•āĻžāϰāϪ⧇ āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āĻ—āĻ āύāĻ—āϤ āĻ•ā§āώāϝāĻŧāĨ¤

Neurological Causes / āĻ¸ā§āύāĻžāϝāĻŧāĻŦāĻŋāĻ• āĻ•āĻžāϰāĻŖ

Lumbar Disc Herniation: āĻĄāĻŋāĻ¸ā§āϕ⧇āϰ āĻ…āĻ‚āĻļ āĻŦāĻžāχāϰ⧇ āĻŦ⧇āϰāĻŋāϝāĻŧ⧇ āĻ¸ā§āύāĻžāϝāĻŧ⧁āĻŽā§‚āϞ⧇ āϚāĻžāĻĒ āĻŦāĻž āĻĒā§āϰāĻĻāĻžāĻš āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāĻžāĨ¤

Lumbar Radiculopathy: āϕ⧋āĻŽāϰ⧇āϰ nerve root āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻ“āϝāĻŧāĻžāĨ¤

Inflammatory Causes / āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āĻ•āĻžāϰāĻŖ

Axial Spondyloarthritis: āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄ āĻ“ sacroiliac joint-āĻāϰ āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āϰ⧋āĻ—āĨ¤

Serious Causes / āϗ⧁āϰ⧁āϤāϰ āĻ•āĻžāϰāĻŖ

Vertebral fracture, spinal infection, malignancy āĻŦāĻž cauda equina syndromeāĨ¤

10.3 Pathophysiology — āϰ⧋āϗ⧇āϰ āĻ•āĻžāĻ°ā§āϝāĻĒāĻĻā§āϧāϤāĻŋ

Mechanical LBP-āĻ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ pain-sensitive tissue āĻĨ⧇āϕ⧇ nociceptive signals āϤ⧈āϰāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Nociception: āĻ•ā§āώāϤāĻŋāĻ•āϰ āĻŦāĻž āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•ā§āώāϤāĻŋāĻ•āϰ āωāĻĻā§āĻĻā§€āĻĒāύāĻžāϰ āĻĢāϞ⧇ āĻŦā§āϝāĻĨāĻžāϰ āϏāĻ‚āϕ⧇āϤ āϤ⧈āϰāĻŋ āĻšāĻ“āϝāĻŧāĻžāϰ āĻĒā§āϰāĻ•ā§āϰāĻŋāϝāĻŧāĻžāĨ¤

Inflammatory Mediators: Prostaglandins āĻ“ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ inflammatory mediators āĻŦā§āϝāĻĨāĻžāϰ āϏāĻ‚āĻŦ⧇āĻĻāύ āĻŦāĻžāĻĄāĻŧāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Muscle Spasm: āĻ•āĻŋāϛ⧁ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻŦā§āϝāĻĨāĻž āĻ“ protective muscle contraction āĻāϕ⧇ āĻ…āĻ¨ā§āϝāϕ⧇ āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻ•āϰ⧇ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ āĻŦāĻžāĻĄāĻŧāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Pathophysiology Confidence: 0.98 — āϏāĻžāϧāĻžāϰāĻŖ āϰ⧋āĻ—āϤāĻ¤ā§āĻ¤ā§āĻŦ; āĻāχ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ mechanism āĻĒā§āϰāĻŽāĻžāĻŖāĻŋāϤ āύāϝāĻŧāĨ¤


đŸŸĸ SECTION 11 | Clinical Features & Symptoms / āϰ⧋āϗ⧇āϰ āϞāĻ•ā§āώāĻŖ

Typical Features of Mechanical Low Back Pain

Localized Lumbar Pain: āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻŦā§āϝāĻĨāĻžāĨ¤

Pain with Movement: āύāĻĄāĻŧāĻžāϚāĻĄāĻŧāĻžāϝāĻŧ āĻŦā§āϝāĻĨāĻž āĻŦ⧃āĻĻā§āϧāĻŋāĨ¤

Muscle Tenderness: āĻĒ⧇āĻļāĻŋāϤ⧇ āϚāĻžāĻĒ āĻĻāĻŋāϞ⧇ āĻŦā§āϝāĻĨāĻžāĨ¤

Reduced Range of Motion: āϕ⧋āĻŽāϰ āύāĻĄāĻŧāĻžāϚāĻĄāĻŧāĻžāϰ āϏ⧀āĻŽāĻžāĻŦāĻĻā§āϧāϤāĻžāĨ¤

Features Suggesting Radiculopathy

Radiating Leg Pain: āĻĒāĻžāϝāĻŧ⧇āϰ āĻĻāĻŋāϕ⧇ āĻ›āĻĄāĻŧāĻžāύ⧋ āĻŦā§āϝāĻĨāĻžāĨ¤

Paresthesia: āĻāĻŋāύāĻāĻŋāύāĻŋ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāĨ¤

Numbness: āĻ…āĻŦāĻļāĻ­āĻžāĻŦāĨ¤

Motor Weakness: āĻĒ⧇āĻļāĻŋāϰ āĻļāĻ•ā§āϤāĻŋ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

Red Flag Symptoms / āϜāϰ⧁āϰāĻŋ āĻŦāĻŋāĻĒāĻœā§āϜāύāĻ• āϞāĻ•ā§āώāĻŖ

āύāĻŋāĻšā§‡āϰ āϞāĻ•ā§āώāĻŖāϗ⧁āϞ⧋ āĻĨāĻžāĻ•āϞ⧇ āĻĻā§āϰ⧁āϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āϜāϰ⧁āϰāĻŋ:

  • New urinary retention or incontinence — āύāϤ⧁āύ āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ āφāϟāϕ⧇ āϝāĻžāĻ“āϝāĻŧāĻž āĻŦāĻž āύāĻŋāϝāĻŧāĻ¨ā§āĻ¤ā§āϰāĻŖ āĻšāĻžāϰāĻžāύ⧋āĨ¤
  • Saddle anesthesia — āϝ⧌āύāĻžāĻ™ā§āĻ— āĻŦāĻž āĻĒāĻžāϝāĻŧ⧁āĻĒāĻĨ⧇āϰ āφāĻļāĻĒāĻžāĻļ⧇ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤
  • Progressive leg weakness — āĻĒāĻžāϝāĻŧ⧇āϰ āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž āĻ•ā§āϰāĻŽāĻžāĻ—āϤ āĻŦ⧃āĻĻā§āϧāĻŋāĨ¤
  • Fever with severe back pain — āϤ⧀āĻŦā§āϰ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāϰ āϏāĻ™ā§āϗ⧇ āĻœā§āĻŦāϰāĨ¤
  • Major trauma — āĻŦāĻĄāĻŧ āφāϘāĻžāϤāĨ¤
  • Known malignancy with new unexplained back pain — āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āχāϤāĻŋāĻšāĻžāϏāϏāĻš āύāϤ⧁āύ āĻ…āĻ•āĻžāϰāĻŖ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāĨ¤

Clinical Confidence: 0.98


đŸŸĸ SECTION 12 | Differential Diagnosis / āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϰ⧋āĻ—

DiagnosisāĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨSupporting EvidenceAssessment Confidence
Nonspecific Low Back PaināĻ…āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻžāϰāϪ⧇āϰ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžProbable LBP notation0.78
Mechanical Low Back PaināϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāϪ⧇ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžPossible musculoskeletal treatment pattern0.68
Lumbar Muscle Spasmāϕ⧋āĻŽāϰ⧇āϰ āĻĒ⧇āĻļāĻŋāϤ⧇ āĻ–āĻŋāρāϚ⧁āύāĻŋPossible Relentus use0.61
Lumbar Radiculopathyāϕ⧋āĻŽāϰ⧇āϰ āĻ¸ā§āύāĻžāϝāĻŧ⧁āĻŽā§‚āϞ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻ“āϝāĻŧāĻžRadicular symptoms undocumented0.42
Lumbar Disc Herniationāϕ⧋āĻŽāϰ⧇āϰ āĻĄāĻŋāĻ¸ā§āĻ• āĻŦ⧇āϰāĻŋāϝāĻŧ⧇ āφāϏāĻžNo imaging or neurological findings0.30
Lumbar Spondylosisāϕ⧋āĻŽāϰ⧇āϰ āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āĻ•ā§āώāϝāĻŧNo confirmatory history or imaging0.30
OsteoporosisāĻšāĻžāĻĄāĻŧ⧇āϰ āϘāύāĻ¤ā§āĻŦ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻžSante alone is insufficient evidence0.20
OsteomalaciaāĻšāĻžāĻĄāĻŧ⧇āϰ āĻ–āύāĻŋāϜāĻžāϝāĻŧāύ⧇ āϏāĻŽāĻ¸ā§āϝāĻžNo metabolic assessment0.15

Interpretation: 0.40-āĻāϰ āύāĻŋāĻšā§‡āϰ diagnosisāϗ⧁āϞ⧋ āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ evidence-supported working diagnosis āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ—ā§āϰāĻšāĻŖāϝ⧋āĻ—ā§āϝ āύāϝāĻŧāĨ¤ āĻāϗ⧁āϞ⧋ āĻļ⧁āϧ⧁ āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ differential considerationāĨ¤


đŸŸĸ SECTION 13 | DOCTOR’S DX vs MY DX — CLINICAL COMPARISON

đŸŸĸ Similarities / āĻŽāĻŋāϞ

1. Doctor’s Probable Dx: LBP — Low Back PaināĨ¤

My Dx: Low Back Pain, Etiology UndeterminedāĨ¤

Similarity: āĻŽā§‚āϞ āωāĻĒāϏāĻ°ā§āϗ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻŽāĻŋāϞ āϰāϝāĻŧ⧇āϛ⧇āĨ¤

2. Prescribed Analgesic: FlexiāĨ¤

My Interpretation: āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāϰ symptomatic treatmentāĨ¤

Similarity: āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽā§‡āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇āϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

3. Possible Muscle Relaxant: RelentusāĨ¤

My Interpretation: Muscle spasm āϏāĻ¨ā§āĻĻ⧇āĻšā§‡ prescribing āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Similarity: āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ musculoskeletal treatment strategy-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

🟧 Differences / āĻ…āĻŽāĻŋāϞ

1. Mechanical Origin: āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āύ⧋āĻŸā§‡ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āϞ⧇āĻ–āĻž āύ⧇āχ; āφāĻŽāĻžāϰ assessment-āĻ āĻāϟāĻŋ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖāĨ¤

2. Lumbar Muscle Spasm: āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ examination finding āύ⧇āχ; āĻ“āώ⧁āϧ⧇āϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āϏāĻ¨ā§āĻĻ⧇āĻš āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

3. Calcium Deficiency/Osteoporosis: Sante āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻ•āĻžāϰāϪ⧇ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

4. Lumbar Radiculopathy: āĻ¸ā§āύāĻžāϝāĻŧāĻŦāĻŋāĻ• āϞāĻ•ā§āώāϪ⧇āϰ āϤāĻĨā§āϝ āĻ›āĻžāĻĄāĻŧāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Final Comparison Table

Clinical ParameterDoctor’s DocumentationMy Working Assessment
Main DiagnosisProbable LBPLBP
EtiologyNot documentedUndetermined
Mechanical OriginNot confirmedSuspected
Muscle SpasmNot documentedPossible
Calcium DeficiencyNot documentedNot established
OsteoporosisNot documentedNot established
RadiculopathyNot documentedRequires clinical evidence
Diagnostic StatusSymptom-levelProvisional

đŸŸĸ Final Similarity

Doctor’s probable diagnosis and my working diagnosis are consistent at the level of Low Back Pain.

🟧 Final Difference

āφāĻŽāĻžāϰ assessment-āĻ āĻ•āĻŋāϛ⧁ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāϪ⧇āϰ āφāϞ⧋āϚāύāĻž āϰāϝāĻŧ⧇āϛ⧇, āϝāĻž āĻāĻ–āύ⧋ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āύāĻĨāĻŋāϭ⧁āĻ•ā§āϤ examination āĻŦāĻž investigation āĻĻā§āĻŦāĻžāϰāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāϝāĻŧāύāĻŋāĨ¤

Comparison Confidence: 0.89


đŸŸĸ SECTION 14 | Evidence-Based Management / āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻžāĻ­āĻŋāĻ¤ā§āϤāĻŋāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž

14.1 Non-Pharmacological Management

A. Patient Education

āϰ⧋āĻ—ā§€āϕ⧇ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖ, āĻ•āĻžāĻ°ā§āϝāĻ•āϞāĻžāĻĒ āĻāĻŦāĻ‚ expected recovery āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āĻŦā§‹āĻāĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤

B. Maintain Normal Activity

āϏāĻšāύ⧀āϝāĻŧ āϏ⧀āĻŽāĻžāϰ āĻŽāĻ§ā§āϝ⧇ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ•āĻžāϜ āϚāĻžāϞāĻŋāϝāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻžāϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļāĨ¤

C. Exercise Therapy

Clinical assessment āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ walking, flexibility exercise āĻāĻŦāĻ‚ progressive strengthening āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤

D. Physiotherapy

āĻ•āĻžāĻ°ā§āϝāĻ•ā§āώāĻŽāϤāĻž āĻ•āĻŽā§‡ āϗ⧇āϞ⧇ āĻŦāĻž āωāĻĒāϏāĻ°ā§āĻ— āĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āĻšāϞ⧇ structured exercise-based rehabilitationāĨ¤

E. Avoid Prolonged Bed Rest

āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ bed rest āϏāĻžāϧāĻžāϰāĻŖ nonspecific LBP-āĻ āωāĻĒāĻ•āĻžāϰ⧀ āύāϝāĻŧāĨ¤

14.2 Pharmacological Management

A. NSAIDs

NICE NG59 āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ oral NSAIDs āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝāĻžāϝāĻŧāĨ¤

Principle: Lowest effective dose for the shortest possible duration.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻŦāĻšā§‡āϝāĻŧ⧇ āĻ•āĻŽ āĻ•āĻžāĻ°ā§āϝāĻ•āϰ āĻŽāĻžāĻ¤ā§āϰāĻž, āϏāĻŦāĻšā§‡āϝāĻŧ⧇ āĻ•āĻŽ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āϏāĻŽāϝāĻŧāĨ¤

B. Muscle Relaxants

Chronic primary LBP-āĻ routine muscle relaxant therapy WHO 2023 āϏ⧁āĻĒāĻžāϰāĻŋāĻļ āĻ•āϰ⧇ āύāĻžāĨ¤

C. Proton Pump Inhibitors

NSAID-associated GI risk āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ gastroprotection āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

D. Calcium/Vitamin C Supplement

Calcium āĻŦāĻž Vitamin C-āĻāϰ āϘāĻžāϟāϤāĻŋ, dietary insufficiency āĻŦāĻž āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ clinical indication āĻĨāĻžāĻ•āϞ⧇ Sante āωāĻĒāϝ⧁āĻ•ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Routine Sante supplementation solely for nonspecific low back pain is not guideline-established treatment.

E. Avoid Unnecessary Medicines

Duplicate NSAIDs, unnecessary opioids, routine gabapentinoids āĻāĻŦāĻ‚ āĻ…āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāϤ long-term medication āĻāĻĄāĻŧāĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤

Management Confidence: 0.98


đŸŸĸ SECTION 15 | Overview / Summary — āϏāĻžāϰāϏāĻ‚āĻ•ā§āώ⧇āĻĒ

Prescription Summary

āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āϏāĻŽā§āĻ­āĻŦāϤ Low Back Pain (LBP) āωāĻ˛ā§āϞ⧇āĻ– āϰāϝāĻŧ⧇āϛ⧇āĨ¤

āϏāĻ‚āĻļā§‹āϧāĻŋāϤ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āϚāĻžāϰāϟāĻŋ āĻ“āώ⧁āϧ:

1. Flexi 100 mg (Aceclofenac): āĻŦā§āϝāĻĨāĻž āĻ“ āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋āϰ NSAIDāĨ¤

2. Seclo 20 mg (Omeprazole): āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āĻ…ā§āϝāĻžāϏāĻŋāĻĄ āĻ•āĻŽāĻžāύ⧋āϰ PPI; āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ gastroprotectionāĨ¤

3. Relentus (Tizanidine): āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ painful spasm āĻ•āĻŽāĻžāύ⧋āϰ āĻ“āώ⧁āϧāĨ¤

4. Sante (Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C): Calcium āĻ“ Vitamin C supplementāĨ¤

Clinical Conclusion

Most Likely Working Diagnosis: Low Back Pain of Undetermined Etiology, with a Possible Mechanical Component.

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāϰāĻŖ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āύāϝāĻŧ āĻāĻŽāύ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻž, āϝāĻžāϰ āϏāĻ™ā§āϗ⧇ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāĻŖ āĻ“ āĻĒ⧇āĻļāĻŋāϰ āϟāĻžāύ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Sante-āĻāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāχ āϰ⧋āĻ—ā§€āϰ osteoporosis āĻŦāĻž calcium deficiency āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰ⧇ āύāĻžāĨ¤

Summary Confidence: 0.89


đŸŸĸ SECTION 16 | Actionable Clinical Plan, Prescription Demo & Referral / āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒāϰāĻŋāĻ•āĻ˛ā§āĻĒāύāĻž, āύāĻŽā§āύāĻž āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻ“ āϰ⧇āĻĢāĻžāϰ

A. Clinical Action Plan

Step 1 — History Taking: āĻŦā§āϝāĻĨāĻžāϰ āĻļ⧁āϰ⧁, āĻ¸ā§āĻĨāĻžāϝāĻŧāĻŋāĻ¤ā§āĻŦ, āĻĒā§āϰāĻ•ā§ƒāϤāĻŋ, āĻĒāĻžāϝāĻŧ⧇ āĻ›āĻĄāĻŧāĻžāϝāĻŧ āĻ•āĻŋ āύāĻž āĻāĻŦāĻ‚ red flag symptoms āϜāĻžāύāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 2 — Physical Examination: Lumbar ROM, spinal tenderness, SLR, motor power, sensation āĻ“ reflex āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 3 — Risk Assessment: NSAID āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āφāϗ⧇ renal, GI, cardiovascular āĻāĻŦāĻ‚ pregnancy-related risk āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 4 — Rational Investigation: Red flag āĻŦāĻž āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ clinical indication āύāĻž āĻĨāĻžāĻ•āϞ⧇ routine MRI/X-ray āĻāĻĄāĻŧāĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 5 — Treatment Review: Analgesic response, function, adverse effects āĻāĻŦāĻ‚ rehabilitation progress āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 6 — Supplement Review: Sante-āĻāϰ āĻĒā§āϰāĻ•ā§ƒāϤ clinical indication āφāϛ⧇ āĻ•āĻŋ āύāĻž āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Action Plan Confidence: 0.98


B. Realistic Clinical Prescription Demonstration

Educational Example — āĻļāĻŋāĻ•ā§āώāĻžāĻŽā§‚āϞāĻ• āύāĻŽā§āύāĻž

āύāĻŋāĻšā§‡āϰ āωāĻĻāĻžāĻšāϰāĻŖāϟāĻŋ āĻŽā§‚āϞ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϰ⧋āĻ—ā§€āϰ āϜāĻ¨ā§āϝ āύāϝāĻŧāĨ¤

Hypothetical Patient: 35-year-old adult with five days of uncomplicated nonspecific low back pain, normal neurological examination, no red flags, no pregnancy, no renal disease and no NSAID contraindicationsāĨ¤

C/C: Low Back Pain for 5 days — āĻĒāĻžāρāϚ āĻĻāĻŋāύ āϧāϰ⧇ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāĨ¤

O/E: Lumbar movement-related pain; neurological examination normal — āϕ⧋āĻŽāϰ āύāĻĄāĻŧāĻžāϚāĻĄāĻŧāĻžāϝāĻŧ āĻŦā§āϝāĻĨāĻž, āĻ¸ā§āύāĻžāϝāĻŧāĻŦāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āĨ¤

Working Dx: Acute Nonspecific Mechanical Low Back Pain — āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϤ⧀āĻŦā§āϰ āĻ…āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻžāĨ¤

Rx — Illustrative Treatment

1. Tab. Aceclofenac 100 mg

For an appropriately selected adult, the reference regimen is 100 mg orally twice daily, for the shortest necessary period, with reassessment and renal/GI/cardiovascular risk reviewāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āωāĻĒāϝ⧁āĻ•ā§āϤ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻ¸ā§āĻŦāĻ˛ā§āĻĒāĻŽā§‡āϝāĻŧāĻžāĻĻāĻŋ āĻŦā§āϝāĻĨāĻž āύāĻŋāϝāĻŧāĻ¨ā§āĻ¤ā§āϰāϪ⧇ NSAID āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝāĻžāϝāĻŧāĨ¤

2. Cap. Omeprazole 20 mg

Consider once daily when gastroprotection is indicated, particularly with relevant NSAID-associated GI riskāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āφāϞāϏāĻžāϰ⧇āϰ āĻā§āρāĻ•āĻŋ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤

3. Tab. Tizanidine

Not routinely prescribed in this demonstration. Clinically significant painful spasm āĻĨāĻžāĻ•āϞ⧇ āĻāĻŦāĻ‚ sedation, hypotension āĻ“ interaction risk āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ⧇āϰ āĻĒāϰ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

4. Sante Effervescent Tablet

Not routinely prescribed solely for nonspecific back pain.

Documented āĻŦāĻž clinically justified calcium/vitamin C supplementation-āĻāϰ āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻĨāĻžāĻ•āϞ⧇ MedEx adult reference āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻĻāĻŋāύ⧇ āĻāĻ•āϟāĻŋ tablet āĻĒāĻžāύāĻŋāϤ⧇ āϗ⧁āϞāĻŋāϝāĻŧ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āύ⧇āĻ“āϝāĻŧāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Advice — āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ

Continue tolerable activity — āϏāĻšāύ⧀āϝāĻŧ āĻ•āĻžāϜ āϚāĻžāϞāĻŋāϝāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻžāĨ¤

Avoid prolonged bed rest — āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ āĻŦāĻŋāĻ›āĻžāύāĻžāϝāĻŧ āĻļ⧁āϝāĻŧ⧇ āύāĻž āĻĨāĻžāĻ•āĻžāĨ¤

Begin appropriate exercises — āωāĻĒāϝ⧁āĻ•ā§āϤ āĻŦā§āϝāĻžāϝāĻŧāĻžāĻŽ āĻļ⧁āϰ⧁ āĻ•āϰāĻžāĨ¤

Return urgently if neurological red flags develop — āύāϤ⧁āύ āĻ¸ā§āύāĻžāϝāĻŧāĻŦāĻŋāĻ• āĻŦāĻŋāĻĒāĻœā§āϜāύāĻ• āϞāĻ•ā§āώāĻŖ āĻĻ⧇āĻ–āĻž āĻĻāĻŋāϞ⧇ āϜāϰ⧁āϰāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύ⧇āĻ“āϝāĻŧāĻžāĨ¤

Follow-Up

āĻŦā§āϝāĻĨāĻž, āĻĻ⧈āύāĻ¨ā§āĻĻāĻŋāύ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āώāĻŽāϤāĻž, medication response āĻ“ adverse effects āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻĒ⧁āύāĻ°ā§āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύāĨ¤


C. Specific Diagnosis for Clinical Prescription Note

Recommended Working Dx

Dx: Low Back Pain (LBP), Etiology Undetermined — Suspected Nonspecific Mechanical Low Back Pain ± Lumbar Muscle Spasm.

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāϰāĻŖ āĻ…āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻž; āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāĻŖ āĻāĻŦāĻ‚ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ āϟāĻžāύ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Referral

Primary: Orthopedics SpecialistāĨ¤

Alternative: Physical Medicine & Rehabilitation SpecialistāĨ¤

Emergency: Suspected cauda equina syndrome āĻŦāĻž progressive neurological deficit āĻĨāĻžāĻ•āϞ⧇ urgent spinal specialist assessmentāĨ¤

Prescription-Note Confidence: 0.91 — āĻāĻ•āϟāĻŋ conservative, symptom-grounded provisional note āĻšāĻŋāϏ⧇āĻŦ⧇ āωāĻĒāϝ⧁āĻ•ā§āϤ; āύāĻŋāĻļā§āϚāĻŋāϤ underlying pathology āύāϝāĻŧāĨ¤


đŸŸĸ SECTION 17 | REFERENCE LIST — TEXTBOOKS, GUIDELINES & DOI

A. Standard Medical Textbooks

1. Harrison’s Principles of Internal Medicine. 22nd Edition. McGraw Hill; 2025.

Relevant topics: Back pain, neurological assessment, musculoskeletal disordersāĨ¤

2. Davidson’s Principles and Practice of Medicine. 24th Edition. Elsevier; 2022.

Relevant topics: Musculoskeletal medicine and assessment of paināĨ¤

3. Apley’s System of Orthopaedics and Fractures. 10th Edition. CRC Press; 2018.

Relevant topics: Disorders of the spine and low back paināĨ¤

4. Katzung BG, Vanderah TW. Basic & Clinical Pharmacology.

Relevant chapters: NSAIDs, skeletal muscle relaxants, gastrointestinal pharmacology and mineral supplementationāĨ¤

5. Goodman & Gilman’s The Pharmacological Basis of Therapeutics.

Relevant topics: Anti-inflammatory drugs, gastric acid inhibitors and centrally acting medicationsāĨ¤

Reference Note: āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ page number āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšāϝāĻŧāύāĻŋ, āϤāĻžāχ āĻ…āύ⧁āĻŽāĻžāύ āĻ•āϰ⧇ page number āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāĻšā§āϛ⧇ āύāĻžāĨ¤


B. International Guidelines

1. NICE NG59

Low Back Pain and Sciatica in Over 16s: Assessment and Management.

Published 2016; pharmacological recommendations amended 2020āĨ¤

NICE NG59 — Official Guideline

2. WHO 2023

WHO Guideline for Non-Surgical Management of Chronic Primary Low Back Pain in Adults.

WHO 2023 — Official Guideline

3. VA/DoD 2022

VA/DoD Clinical Practice Guideline: Diagnosis and Treatment of Low Back Pain.

VA/DoD 2022 — Official Guideline


C. Peer-Reviewed Journals with DOI

1. The Lancet

Hartvigsen J, Hancock MJ, Kongsted A, et al.

What Low Back Pain Is and Why We Need to Pay Attention.

The Lancet. 2018;391(10137):2356–2367.

DOI: 10.1016/S0140-6736(18)30480-X.

Read Journal Article

2. Annals of Internal Medicine

Qaseem A, Wilt TJ, McLean RM, Forciea MA.

Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.

Ann Intern Med. 2017;166(7):514–530.

DOI: 10.7326/M16-2367.

Read Journal Article


D. MedEx Bangladesh — Official Drug References

DrugVerified GenericMedEx Reference
Flexi 100 mgAceclofenacFlexi
Seclo 20 mgOmeprazoleSeclo
Relentus 2 mgTizanidine HydrochlorideRelentus
SanteCalcium Lactate Gluconate + Calcium Carbonate + Vitamin CSante

🟧 FINAL CLINICAL ASSESSMENT — DIAGNOSTIC VERDICT

1. Doctor’s Probable Diagnosis

Low Back Pain (LBP).

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āĻŽāϰ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻžāĨ¤

2. My Clinical Working Diagnosis

Low Back Pain, Etiology Undetermined — Suspected Nonspecific Mechanical Low Back Pain with Possible Lumbar Muscle Spasm.

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāϰāĻŖ āĻ…āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āϕ⧋āĻŽāϰāĻŦā§āϝāĻĨāĻž; āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝāĻžāĻ¨ā§āĻ¤ā§āϰāĻŋāĻ• āĻ•āĻžāϰāĻŖ āĻ“ āĻŽāĻžāĻ‚āϏāĻĒ⧇āĻļāĻŋāϰ āϟāĻžāύ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

3. Doctor’s Diagnosis vs My Diagnosis

đŸŸĸ Similarity: āĻĒā§āϰāϧāĻžāύ āωāĻĒāϏāĻ°ā§āĻ— Low Back Pain-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻŽāĻŋāϞ āϰāϝāĻŧ⧇āϛ⧇āĨ¤

🟠 Difference: Muscle spasm āĻ“ mechanical origin āφāĻŽāĻžāϰ differential-based clinical interpretation, confirmed examination findings āύāϝāĻŧāĨ¤

4. Corrected Fourth Medicine

Sante — Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C.

Purpose: Calcium āĻ“ Vitamin C supplementationāĨ¤

Clinical Interpretation: āĻšāĻžāĻĄāĻŧ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻŦāĻž āĻĒ⧁āĻˇā§āϟāĻŋāĻ—āϤ āϘāĻžāϟāϤāĻŋāϰ āϏāĻšāĻžāϝāĻŧāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇; osteoporosis āĻŦāĻž calcium deficiency āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰ⧇ āύāĻžāĨ¤

5. Final Diagnosis for Prescription Note

Dx: Low Back Pain (LBP), Etiology Undetermined; Suspected Mechanical LBP Âą Lumbar Muscle Spasm.

6. Specialist Referral

Orthopedics / Physical Medicine & Rehabilitation Specialist.

7. Overall Diagnostic Confidence

0.78/1.00 — Moderate-to-High Confidence for Symptom-Level Working Assessment.

āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ structural āĻŦāĻž metabolic disease-āĻāϰ āϜāĻ¨ā§āϝ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ evidence āύ⧇āχāĨ¤


Author Name: Md.Rafiqul Islam Lipu

Publication Date: Wednesday, 21 October 2026

Time: 05:16 PM (Bangladesh Standard Time, UTC+06:00)

Department: Orthopedics

Proposed TC Number: 1419

Proposed Department Case Number: 185

LIPU MED — Evidence-Based Clinical Prescription Review

Disclaimer: āĻāχ āύāĻŋāĻŦāĻ¨ā§āϧāϟāĻŋ prescription-based retrospective educational assessmentāĨ¤ āϰ⧋āĻ—ā§€āϰ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āχāϤāĻŋāĻšāĻžāϏ, āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ“ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ investigation āĻ›āĻžāĻĄāĻŧāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ āĻŦāĻž āĻŦā§āϝāĻ•ā§āϤāĻŋāĻ—āϤ āĻ“āώ⧁āϧ⧇āϰ regimen āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top